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INTRODUCTION 
I. RNA Polymerase II (RNAPII) and the Transcription Cycle 
In eukaryotes, there are three multi-subunit RNA polymerase enzymes that are 
responsible for gene transcription, RNA polymerase I, II and III. RNA polymerase II 
(RNAPII) is responsible for synthesizing all protein-coding RNAs and many non-coding 
RNAs including small nuclear RNAs and microRNAs. RNAPII is a 514 kDa complex 
consisting of 10-core subunits and two heterodimer subunits Rpb4 and Rpb7 that 
associate with the 10-core subunits (Bushnell and Kornberg, 2003). Some of the subunits 
are conserved and share structural and sequence homology with subunits of RNAPI and 
RNAPIII (reviewed in Cramer et al., 2008). Five of the subunits are common to all three 
eukaryotic RNA polymerases. A crystal structure of the complete 12 subunits of RNAPII 
is shown in Figure 1. 
 
 
Figure 1.  A ribbon representation of the 12-subunits of RNAPII. Black arrow indicates 
the position of Rpb4 and Rpb7 heterodimer.  
Rpb4/Rpb7
10-core subunits 
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RNAPII is subject to regulation at all stages of the transcription cycle including 
initiation, elongation and termination. In particular, regulatory factors (activators or 
repressors) bind to specific gene sequences at the promoter near the transcription start site 
and initiate or repress transcription by either interacting with transcription machinery or 
by recruiting factors that modify chromatin structure (reviewed in Hahn, 2004). The core 
promoter acts as platform for the assembly of transcription pre-initiation complex (PIC). 
PIC includes general transcription factors TFIID, TFIIB, TFIIE, TFIIF and RNAPII 
(reviewed in Thomas and Chiang, 2006). PIC assembly begins with the binding of TATA 
binding protein that promotes the binding of other transcription factors and the recruiting 
of RNAPII at the gene promoter. There are two proposed pathways for the order of entry 
of the general factors. First pathway describes a sequential assembly of the factors and 
RNAPII at the promoter (Buratowski et al., 1989) whereas the second pathway describes 
a preassembled holoenzyme RNAPII (Kim el at., 1994). After PIC formation, DNA 
strands are separated and the template strand is inserted into RNAPII active site resulting 
in open promoter complex that allows the synthesis of nascent RNA from the 
transcription start site (Treutlein et al., 2012). 
After the nascent RNA reaches ~ 30 nucleotides in length, RNAPII escapes the 
promoter to enter early elongation stage. The transition from early elongation to 
productive elongation is accompanied with promoter-proximal pausing in mammals, 
which is a regulatory process of transcription. RNAPII can escape the pausing state to 
productive elongation through the action of positive elongation factor (P-TEFb). Several 
RNA processing factors and histone modifying proteins are recruited to elongation 
complex and interacted with RNAPII such as TREX complex and FACT complex 
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respectively (reviewed in Guo et al.2013; Kwak et al., 2013; Zhou et al., 2012).  The 
termination of the transcription cycle occurs when RNAPII and the newly synthesized 
RNA are released from the DNA template. Termination of transcription requires poly (A) 
signal and is coupled with RNA 3ʹ end processing. Termination is an important 
regulatory process because it prevents interference with downstream elements for 
example downstream promoters and it promotes RNAPII recycling (reviewed in 
Kuehner, 2011). 
 
II. The C-terminal Domain (CTD) of RNAPII 
Although RNAPII shares structural homology with RNAPI and RNAPIII, it 
possesses a unique C-terminal domain (CTD) at its largest subunit Rpb1. CTD comprises 
multiple tandem repeats of heptapeptide with the consensus: Tyr-Ser-Pro-Thr-Ser-Pro-
Ser, the amino acids are numbered one to seven: Y1S2P3T4S5P6S7 (reviewed in Corden 
1990). The number of the heptapeptide repeats varies among different organisms, for 
example yeast S. cerevisiae has 27 repeats whereas mammals and Drosophila have 52 
and 42 repeats respectively (reviewed in Prelich, 2002). It has been established that the 
importance of the number of the repeats and the critical function of each amino acid 
among the repeats differ among organisms (reviewed in Jasnovidova and Stefl, 2013). 
Truncation studies demonstrated that removing more than half of the heptapeptide repeats 
in yeast S. cerevisiae results in growth defects, for example cells containing 10-12 
complete heptapeptide repeats are conditionally viable whereas cells containing fewer 
than 10 repeats are not viable (Nonet et al., 1987). In addition, substitution of Ser2 or  
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Ser5 to alanine or glutmatae is lethal in yeast S. cerevisiae as well as the substitution of 
Tyr1 to phenylalanine (West et al., 1995). In contrast, mutation of Ser2 to alanine is not 
lethal in yeast S. pombe during vegetative growth, but is required for mating (Schwer et 
al., 2011).  
During transcription, the CTD undergoes a cycle of dynamic post-translational 
modifications most frequently phosphorylation with five potential sites for 
phosphorylation (Y1, S2, T4, S5, and S7). However, the main phosphorylation sites that 
have been identified are Ser2, Ser5 and Ser7 (reviewed in Jasnovidova and Stefl, 2013). 
Several protein kinases have been identified as responsible for CTD phosphorylation in 
mammals and yeast (Table 1), the kinases are TFIIH cyclin-dependent kinase 
(Cdk7/Kin28), mediator-associated kinase (Cdk8/Srb10), and P-TEFb kinase (Cdk9/Ctk-
1 and Bur1) (reviewed in Buratowski, 2009; Phantnani and Greenleaf, 2006; Prelich, 
2002). Cdk7/Kin28 phosphorylates Ser5 after PIC formation. In yeast TFIIH kinase is 
required for normal transcript levels in vivo, data from microarray experiments have 
shown that the inhibition of Kin28 results in a dramatic reduction of mRNA levels and 
Ser5-P phosphorylation levels (Hong et al., 2009).  
As the RNAPII proceeds in transcription, the level of Ser5-P phosphorylation is 
reduced and the CTD becomes phosphorylated at Ser2 by Cdk9 (mammals) and Ctk-1/ 
Bur1 (yeast). Chromatin immunoprecipitation (ChIP) experiments have shown that the 
greatest level of Ser5-P phosphorylation is observed at the promoter regions whereas the 
greatest level of Ser2-P is observed at the coding regions (Kanin et al., 2007). In addition, 
recent studies have discovered that Ser7 is phosphorylated in vivo by TFIIH kinases in 
mammals and yeast, ChIP signals show enrichment of Ser5-P and Ser7-P at the 5ʹ end 
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and inhibition of TFIIH kinases in vivo results of loss of both marks (Kim et al., 2009; 
Akhtar et al., 2009).  
P-TEFb was first identified as an elongation factor that promotes the release of 
paused RNAPII at the promoter proximal region by phosphorylating Spt4/Spt5 complex a 
subunit of DRB sensitivity inducing factor (DSIF)(reviewed in Guo et al., 2013; Kwak et 
al., 2013). However, recent studies have proposed that Cdk9 kinase of P-TEFb has a dual 
function during elongation. Besides its role in phosphorylating the Spt4/Spt5 complex, it 
also phosphorylates Ser2 of the CTD (reviewed in Guo et al. 2013). In yeast, there are 
two kinases with sequence and functional homology to Cdk9, the kinases are CTDK-1 
(Ctk-1) and Bur 1. It was discovered that Ctk1 primary phosphorylates Ser2 (Cho et al., 
2001) whereas Bur1 phosphorylates Spt4/5 complex as well as Ser2 (Liu et al., 2009). 
Three protein phosphatases (Ssu72, Fcp1, and Rtr1) have been implicated in the 
removal of the phosphate group from the CTD in yeast (Table 1) (reviewed in Hsin and 
Manley, 2012; Mosley et al., 2009). Ssu72 is an essential conserved termination factor 
that has been characterized as a Ser5 phosphatase in the protein tyrosine phosphatase 
superfamily (Ganem et al., 2003). Ssu72 localizes at the 5ʹ and 3ʹ end of the gene with the 
highest enrichment at the 3ʹ end. Depletion of Ssu72 results with increased Ser5-P at the 
3ʹ end but not at the 5ʹ end (Bataille et al., 2012). In addition, Ssu72 depletion impairs 
transcription in vitro (Krishnamurthy et al., 2004). Ssu72 has also been characterized as 
Ser7 phosphatase because it is depletion results in increased Ser7-P at the 3ʹ end (Bataille 
et al., 2012; Zhang et al., 2012) 
Rtr1 an RNA binding protein in yeast was identified as a CTD phosphatase that 
specifically dephosphorylates Ser5-P (Mosley et al., 2009). Experimental analyses in vivo 
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and in vitro have shown that Rtr1, and its human homology, RPAP2 regulate the 
transition of high Ser5-P level to high Ser2-P (Mosley et al., 2009; Ni Z et al., 2014; Hsu 
et al., 2014). ChIP analysis has proven that Rtr1 localizes at the region proceeding Ser2-P 
and not enriched at the promoter region (Mosley et al., 2009). Deletion of Rtr1 causes an 
accumulation of Ser5-P level throughout the coding gene (Mosley et al., 2009).  
Fcp1 interacts with the elongation complex to specifically dephosphorylate Ser2-
P.  ChIP data have indicated that Fcp1 cross-links at the promoter and the coding region 
and Fcp1 mutants cause an increased level of Ser2-P in the coding region (Cho et al., 
1999, 2001). Additionally, Fcp1 has an important role in recycling RNAPII to the hypo-
phosphorylated form for PIC assembly (Cho et al., 1999). 
Table 1.  List of the proposed CTD kinases and phosphatases in S. cerevisiae and 
mammals (reviewed in Hsin and Manley, 2012; Palancade and Bensaude, 2003; 
Buratowski, 2009). 
 
 
III. CTD and Its Binding Proteins 
During transcription cycle several factors and multi-subunits proteins interact 
with RNAPII to regulate transcription and many of these interactions are associated with 
CTD modifications. The CTD serves as a flexible platform for the recruitment of these 
factors and proteins.  
CTD Site Protein/complex   Function S. cerevisiae Mammals 
Ser5, Ser7 TFIIH  Kinase Kin28 Cdk7 
Ser5 Mediator  Kinase  Srb10 Cdk8 
Ser2 P-TEFb  Kinase Ctk1 
Bur1 
Cdk9 
 
Ser5, Ser7 
Ser5                     
 Phosphatase Ssu72 Ssu72 
Scp1 
Ser5  Phosphatase Rtr1 RPAP2 
Ser2  Phosphatase Fcp1 Fcp1 
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Early in transcription hypo-phosphorylated CTD interacts with TBP a subunit of 
TFIID general factor and multi-subunit Mediator complex, the interaction of the CTD 
with these factors helps position RNAPII at the promoter for PIC assembly (Imasaki et 
al., 2011). Phosphorylation of Ser5 by TFIIH kinase disrupts the bonds stabilizing PIC 
complex and triggers the release of RNAPII from the complex (Sogaard and Svejstrup, 
2007). 
The modified CTD mediates the coupling of transcription with RNA processing. 
Multiple RNA processing factors have been described which interact with different 
modified states of the CTD (McCracken et al., 1997). For example Ser5-P CTD interacts 
with RNA capping enzyme; this interaction facilitates the capping of nascent RNA when 
it exists from the active site (Cho et al., 1997). It has been proposed that the capping 
enzyme is recruited to the promoter in TFIIH kinase dependent manner and was 
demonstrated through ChIP assay in S. cerevisiae. ChIP assay has showed that capping 
enzyme is localized to 5ʹ end of the gene but not in the coding region (Komarnitsky et al., 
2000). The coupling of the transcription and capping protects nascent RNA from 
degradation and ensures that is accurately capped.    
In addition to the capping enzyme, The CTD interacts with RNA splicing and 
processing factors with different phosphorylated states for example yeast splicing factor  
Prp40 interacts with hyper-phosphorylated CTD (Morris and Greenleaf, 2000) whereas 
the polyadenylation cleavage factor (Pcf11) interacts with CTD containing only Ser2-P 
(Meinhart and Cramer, 2004). 
Many of the transcription elongation factors that interact with modified CTD 
mediate the coupling of messenger RNA (mRNA) synthesis with mRNA nuclear export 
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such as TREX complex, which interacts with phosphorylated Ser5 and Ser2 (Meinel et al 
2013). In addition several elongation factors facilitate RNAPII elongation through 
chromatin such as PAF and FACT complexes (reviewed in Jaehning, 2010; 
Belotserkovskaya and Reinberg, 2004). However, the precise binding of many of these 
elongation factors with CTD and how these interactions control transcriptional regulation 
is still unknown. Therefore, the work presented here is focused on developing a method 
to isolate the CTD and its binding proteins for proteomics analysis in order to contribute 
of revealing the basis of the interactions of the CTD with these factors. 
 
Introduction to Quantitative Proteomics 
Proteomics in general can be described as the study of all the proteins expressed 
by the genome and the characterization of their features that includes but is not limited to 
expressions, structures, activities, interactions, and post-translational modifications. In 
the post-genomic era, several analytical methods have been developed to provide tools 
for analyzing proteome and the complexity associate with it, among these analytical 
methods is mass spectrometry based-proteomics. Mass spectrometry has proved to be a 
significant tool in identifying protein within a complex as well as investigating protein-
protein interaction because mass spectrometry is very sensitive, reproducible and 
versatile (reviewed in Aebersold and Mann, 2003; Bauer and Kuster, 2003).  
Fundamentally, mass spectrometry measures mass-to-charge ratio (m/z) of ions in 
gas phase. Most mass spectrometer consists of three components including an ion source 
that ionizes analyte molecules, a mass analyzer that separates the ions based on m/z ratio, 
and a detector that records the number of ions (reviewed in Aebersold and Mann, 2003). 
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Electrospray ionization (ESI) and matrix-assisted desorption/ ionization (MALDI) are the 
most common ionization techniques that are capable of ionizing peptides or proteins 
(Fenn et al., 1989; Karas et al., 1988). In mass spectrometry based-proteomics, enzymatic 
digestion of protein mixture followed by separation methods are required prior to mass 
spectrometer analysis to simplify the mixture in order to achieve identification of the 
proteome with high resolution. Previously, two-dimensional protein polyacrylamide gel 
electrophoresis (2D-PAGE) followed with mass spectrometry analysis was the common 
method that provides quantitative analysis for proteomics (reviewed in Hanash, 2000). In 
2D-PAGE method, proteins are separated in first dimension according to isoelectric point 
(pI) by isoelectric focusing and in the second dimension according to the molecular 
weight by SDS-PAGE (O’Farrell, 1975). Following separation, the proteins of interest 
are excised from the gel, treated with enzymatic digestion, and analyzed by mass 
spectrometry (Shevchenko et al., 1996). Although 2D-PAGE is a good method for 
quantitative proteomics, there are several limitations associated with it such as the 
difficulty in detection every proteins in the sample and the incompatibility in detection of 
high pI proteins as well as high molecular weight proteins (Gygi et al., 2000, Oh-Ishi et 
al., 2000).  
Consequently, to overcome the limitations that are associated with 2D- 
electrophoresis method, alternative two-dimensional chromatography separation methods 
were developed by the Yates lab: Link et al., 1999; and Washburn et al., 2001; to provide 
a high-throughput analysis of proteomics. Multi-dimensional protein identification 
technology (MudPIT) is a two-dimensional liquid chromatography (LC) coupled with 
tandem mass spectrometry (MS/MS) (Link et al., 1999; Washburn et al., 2001). In 
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MudPIT, a protein mixture is subjected to enzymatic digestion to yield a mixture of 
peptides, the mixture is then loaded in microcapillary column packed with two or three 
chromatography phases (Link et al., 1999; McDonald et al., 2002). Once the peptide 
mixture is loaded into the column, the peptides are fractionated through the 
chromatography phases (strong cation exchange and reverse- phase matrix) and then the 
peptide fragments are sprayed through high voltage into tandem mass spectrometer for 
analysis. Subsequently, the obtained MS/MS spectra are searched against available 
FASTA protein database using a database search algorithms such as SEQUEST (Link et 
al., 1999).  MudPIT coupled with tandem mass spectrometry has been used successfully 
in identifying large-scale of S. cerevisiae proteome including proteins with large 
molecule weight as well as proteins with a high pI (Washburn et al., 2001; McDonald et 
al., 2002; Mosley et al., 2011). 
In quantitative proteomics, tandem mass spectra (MS/MS) are searched using a 
database search engine such as MASCOT, SEQUEST, Phenyx, and X!Tandem. The 
basic function of these programs is to score the correlation between an experimental 
fragment ion spectrum of a peptide against a theoretical peptide spectrum generated by 
the database search engine (Reviewed in Nesvizhskii et al., 2007). Typically, the output 
of the database-search is a list of proteins and peptides with score presents the number of 
peptide spectrum matches (PSMs) to the theoretical proteins within a set false-discovery 
rate threshold (typically ≤ 5%). Following peptide spectra matching, the proteins and 
peptides are analyzed manually or using program such as Scaffold to provide quantitative 
information including the normalized PSMs values (NSAF) and the level of protein 
enrichments (Mosley et al., 20011and 2013).  
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Previous analyses of the RNAPII protein interacting network using affinity 
purification coupled with MudPIT quantitative analysis have shown that the highest 
protein enrichment levels are assigned to one of 12 subunits of RNAPII when using 
Rpb3, Rpb7, or Rpb11 as a bait of the affinity tag (Mosley et al., 2009, 2011 and 2013). 
These analyses have demonstrated the efficiency of using this approach in identifying 
high abundance proteins that interact with RNAPII during multiple stages of the 
transcription cycle including the elongation factor Spt5/Spt4 and subunits of the general 
transcription factor TFIIF (Tfg1/Tfg2/Taf14) (Mosley et al., 2013). However, they also 
reveal a limitation of this approach in identifying low abundance RNAPII interacting 
proteins that only interact with RNAPII at certain state during transcription cycle. As 
shown in Figure 2 several of low abundance proteins were not detected in MudPIT 
analysis such as Set2, Asr1, Cdc73, Npa3 and Leo1 (Figure 2 is adapted from Mosley et 
al., 2013). 
Consequently, our main objective in the work presented here was to devise a 
method to facilitate the identification of low abundance RNAPII interacting proteins that 
are recruited to the CTD during transcription cycle and participate in controlling 
regulation of transcription. In order to accomplish that, we devised a purification scheme 
that specifically isolate the CTD-associated and CTD-less RNAPII to identify and 
characterize the proteins that interact with both the CTD and the globular core of RNAPII 
including low abundance proteins. 
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Figure 2.  Hierarchical clustering analysis by MudPIT of RNAPII interacting proteins. 
The protein identified by mass spectrometry are listed to the right of the cluster and the 
baits tag proteins are labeled to the top. The yellow squares represent the NSAF 
(normalized PSMs) value and the black squares indicate no protein detection. Black 
arrow to the right indicates the position of high abundance proteins and the red arrow 
indicates the position of low abundance proteins.  
   
I. Method development and Experimental Design 
In the presented work our research objective was designing a novel method to 
isolate CTD of the largest subunit of RNAPII and the CTD interacting proteins in S. 
cerevisiae to improve the identification of low abundance RNAPII interacting proteins. 
Consequently, we have introduced Tobacco etch virus (TEV) protease cleavage site 
(ENLYFGQG) into the flexible linker region of Rpb1 upstream of the CTD using site 
directed-mutagenesis PCR-based method. The site for TEV insertion at the linker region 
was chosen based on work previous done by Kornberg lab. Kornberg and co-workers 
Low abundance 
proteins
High abundance 
proteins
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prepared a CTD-less version of RNAPII by replacement of five amino acids from the 
junction between CTD and the rest of the subunits with Factor Xa (FXa) cleavage site 
(IEGR) (Li and Kornberg, 1994). They used the isolated CTD-less RNAPII for in vitro 
transcription analysis. In addition, they used the CTD-less RNAPII to generate a 3-
dimensional structure of RNAPII by electron crystallography at 16 A˚ resolution 
(Meredith et al., 1996).  
The next approach in our method, was constructing yeast strains express the 
modified Rpb1-TEV gene using various molecular biology methods including 
polymerase chain reaction (PCR) DNA amplification, gene knockout, homologous 
recombination, and 5-fluoroorotic acid (5-FOA) plasmid shuffle. Further to isolate CTD 
and its associated proteins, we performed tandem affinity purification (TAP) to 
specifically purify RNAPII complex and to perform on beads TEV cleavage of the CTD. 
Tandem affinity purification (TAP) developed by Rigaut et al. 1999, is a method to 
isolate protein complexes expressed at their endogenous levels under native conditions. 
The basic concept of TAP purification involves fusing TAP tag to protein of interest then 
introducing the construct into the host cell (Puig et al., 2001). When expressed in the cell, 
the TAP Tagged-protein forms complex with the endogenous partners (Bauer and Kuster, 
2003). Subsequently, the protein complex along with the associated proteins is purified 
using two consecutive affinity steps. The TAP tag consists of two immunoglobulin (IgG) 
binding domains of Staphylococcus aureus protein A (ProtA) and calmodulin binding 
peptide (CBP). The two affinity domains are separated by TEV protease cleavage site 
(Puig et al., 2001; Rigaut et al., 1999).  
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The general procedure of TAP purification is involved the following: the protein 
complex along with the associated proteins is recovered on IgG-coupled resins through a 
strong interaction of IgG with protein A. Further, the protein complex is released from 
the IgG resins by proteolytic cleavage using TEV protease. TEV protease cleavage 
allows the release of the protein A portion of the TAP tag with IgG-coated resins 
effectively eluting the protein of interest and its associated proteins (Rigaut et al., 1999). 
The protein complex is then incubated with calmodulin-coated resins where it becomes 
immobilized to calmodulin resins through calmodulin binding protein (CBP) in the 
presence of calcium. Subsequent to multiple washing steps, the protein complex along 
with the associated proteins is released by using the chelating agent EGTA (Rigaut et al., 
1999; Puig et al., 2001; Bauer and Kuster, 2003). 
The TAP two affinity steps strategy has advantages over regular one-step affinity 
purifications because it significantly reduces non-specific background protein binding 
therefore simplifying the identification and characterization of a protein complex by mass 
spectrometry (Rigaut et al., 1999; Bauer and Kuster, 2003). Another advantage of TAP is 
performing the purification near native conditions avoids the loss of any of the associated 
proteins, which could occur if more stringent conditions are used (Bauer and Kuster, 
2003). In addition, TAP is a valuable method for purifying protein complexes from 
different cellular compartments as well as purifying large protein complexes (Gavin et 
al., 2002). 
In our method, we tagged yeast Rpb3 in strains expressing Rpb1-TEV gene with a 
modified TAP tag. The modified TAP tag has the TEV cleavage site replaced with HR 
3C protease (Human Rhinovirus 3C, hereafter referred to as 3C protease) cleavage site 
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(LEVLFQGP). Additionally, we modified the original TAP purification described above 
to take advantage of TEV cleavage site upstream of the CTD. In general, we performed 
on bead cleavage with TEV protease while the RNAPII complex was immobilized on 
either IgG resins or calmodulin resins. The CTD-less RNAPII complex was released 
from IgG beads by 3C protease cleavage and further was purified through incubation 
with calmodulin beads and eluted with EGTA. The CTD flow-through and the CTD-less 
RNAPII elutions were analyzed in mass spectrometry using the MudPIT method 
followed with quantitative analysis.  A cartoon schematic of our purification model is 
shown in Figure 3.  
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Figure 3.  A cartoon representation of the proposed Rpb3-3C-TAP Rpb1-TEV 
purification scheme. TEV and 3C cleavage sites are shown as following: bottom left and 
top right respectively. The red arrows indicate the protease optimal cleavage site.  
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 MATERIALS AND METHODS  
I. Reagent and Solution Recipe 
Table 2. Recipes of the reagents and solutions used in in this work. 
Reagent      Recipe 
LB- kanamycin media  1% bacto-tryptone, 0.5% yeast extract, 1% NaCl, 50 µg/ml 
kanamycin 
LB-kanamycin Plate  1% bacto-tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar, 
,50 µg/ml kanamycin 
LB- ampicillin media  1% bacto-tryptone, 0.5% yeast extract, 1% NaCl, 100 µg/ml 
ampicillin 
LB-ampicillin Plate 1% bacto-tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar, 
,100 µg/ml ampicillin 
10x TE buffer 100 mM Tris-HCl pH 7.5,  10 mM EDTA pH 8 
TE-LiAc solution pH 
7.5 
100 ul of 10x TE buffer pH 7.5, 100 ul of LiAc, 800 ml 
sterile H2O 
PEG-LiAC solution 100 ul of 10x TE buffer pH 7.5, 100 ul of LiAc, 800 ml 
sterile polyethylene glycol (PEG) 
YPD media 2 % bacto peptone, 1% yeast extract, 2% glucose 
YNB-His
-
 Ura
-
 plate  0.67 % yeast without amino acid extract, 0.077% CSM drop 
out mix (histidine
-
 uracil
-
),), 2% glucose, 2% agar 
YNB-Leu
-
 Ura
-
 plate  0.67 % yeast without amino acid extract, 0.077% CSM drop 
out mix (leucine
-
 uracil
-
), 2% glucose, 2% agar 
YNB-His
-
 Plate  0.67 % yeast nitrogen base without amino acid extract, 
0.077% CSM drop out mix (histidine
 -
), 2% glucose, 2% agar 
YNB-Leu
-
 Plate  0.67 % yeast nitrogen base without amino acid extract, 
0.077% CSM drop out mix (leucine
-
), 2% glucose, 2% agar 
5-fluoroorotic acid (5-
FOA plate 
0.67 % yeast without amino acid extract, 0.077% CSM drop 
out mix (URA3
-
), uracil 25 mg, 2% glucose, 2% agar, 0.1 % 
5-FOA 
1x TBE 100 mM Tris-HCl pH 7.5, 0.5% boric acid, 10 mM EDTA 
pH 8 
1 % agarose gel 1g  agarose in 100 ml 1x TBE 
  
12 % SDS-PAGE   8 ml 1M Tris-HCl pH 8.8, 0.108 ml SDS (20%), 6 ml 
polyacrylamide (40%), 0.108 ml 10% APS, 0.02 ml 
TEMED, 5.8 ml ddH2O 
2 % SDS-PAGE 
stacking gel 
1.14 ml 1M Tris-HCl pH 6.8, 0.04 ml SDS (20%), 0.7 ml 
polyacrylamide (40%), 0.076 ml 10% APS, 0.01 ml 
TEMED, 5.7 ml ddH2O 
1x TGS 25 mM Tris-HCl pH 8, 192 mM glycine, 0.1% SDS (20%) 
Transfer buffer 25mM tris base, 190 mM glycine, 10% methanol and 0.1% 
SDS (20%) 
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1x Tris-Buffered 
Saline (TBS) 
25 mM Tris-HCl pH 7.5, 136 mM NaCl 
5% Blocking Buffer 5 g milk in TBS buffer 
TAP Lysis Buffer 40mM Hepes-KOH, 10% glycerol, 350 mM NaCl, 0.1% 
Tween-20, added prior to use: 1x Yeast protease inhibitors 
(Sigma), and 1mM β-ME 
TEV Cleavage Buffer 10 mM Tris-HCl pH 8, 10% glycerol, 150 mM NaCl, 0.1% 
IPEGAL, 0.5 mM EDTA, added prior to use: 1x Yeast 
protease inhibitors (Sigma), and 1mM β-ME 
3C Cleavage Buffer 50 mM Tris-HCl pH 8, 100 mM NaCl, 1 mM EDTA, added 
prior to use: 1x Yeast protease inhibitors (Sigma), and 1mM 
β-ME 
Calmodulin Binding 
Buffer 
10 mM Tris-HCl pH 8, 1 mM MgOAc, 1 mM imidazole, 2 
mM CaCl2, 100 mM NaCl, 10 % glycerol, added prior to 
use: 1x Yeast protease inhibitors (Sigma), and 1mM β-ME 
Calmodulin Elution 
Buffer 
10 mM Tris-HCl pH 8, 1 mM MgOAc, 1 mM imidazole, 2 
mM EGTA, 100 mM NaCl, 10 % glycerol, added prior to 
use: 1x Yeast protease inhibitors and 1mM β-ME 
CTD Cleavage Buffer 10 mM Tris-HCl pH 8, 150 mM NaCl, 0.1% IPEGAL, 2 mM 
CaCl2, added prior to use: 1x Yeast protease inhibitors 
(Sigma), and 1mM β-ME 
Fixing Solution  30% ethanol, 10 % acetic acid, 60 % MilliQ H2O 
Ethanol Wash  30% ethanol, 70 % MillQ H2O 
Sensitizer Solution 0.02 Sodium thiosulfate in MilliQ H2O (w/v) 
Silver Nitrate Solution 0.1% silver nitrate, 0.02% formaldehyde, 99.9% MilliQ H2O 
Developing Solution  2.5% sodium carbonate, 0.05 % formaldehyde, 0.005 % 
sodium thiosulfate in MilliQ H2O (w/v) 
Stop Solution  0.5 glycine in 100 ml MilliQ H2O (w/v) 
Buffer A 0.5% acetonitrile. 0.1% formic acid 
 
II. Construction of RPB1-TEV-CTD Plasmids  
TEV Insertion Reaction 
To introduce a TEV cleavage site at amino acid 1511 into the linker region of 
RPB1 gene by PCR based site directed mutagenesis, we used a DNA template of S. 
cerevisiae RPB1 gene in pENTR-D-TOPO (Life Technologies, Mosley Lab) (Table 4) 
and RPB1-TEV-1511 forward and reverse primers that were designed in-house (Table 3). 
The insertion reaction was performed using Quick change II XL site directed mutagenesis 
kit (Agilent Technologies, catalog #200521) following a modified procedure of the 
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manufacture instructions. PCR reactions (50 µl) contained 100 ng of pRPB1 template, 3 
µM of each primer, 3µM of dNTP mix, 1 µl of QuickSolution and 2.5 units of PfuUltra 
high fidelity DNA polymerase. The PCR cycles were: 95 °C for 2 minutes followed by 
18 cycles. Each amplification cycle consisted of: 1 minute denaturation at 95 °C, 1 
minute annealing at 55 °C, and 16 minutes extension (2 minutes per kb of template) at 68 
°C. The PCR reaction was completed with final extension for 7 minutes at 68 °C. The 
PCR product was treated with 10 units of Dpn I restriction enzyme at 37 °C for 2 hours to 
digest the parental template, and then 2 µl of Dpn I-treated PCR product was transformed 
to XL10-Gold Ultracompent cells by heat shock for 30 seconds at 42 °C. Subsequently, 
0.5 ml of S.O.C medium (Invitrogen, catalog # 15544-034) was added to the 
transformation reaction followed by incubation for 1 hour at 37 °C with shaking. After 
the incubation was complete, the transformed cells were spread onto LB- kanamycin 
plate and incubated overnight at 37 °C. Following overnight incubation, cells from the 
plate were inoculated in 3 ml of LB-kanamycin media and grown overnight at 37 °C with 
shaking. The next day, the plasmids were purified using QlAPrep spin miniprep kit 
(Qiagen, catalog # 27106) following manufacturer’s instructions and quantified using 
spectrophotometer. And then the purified plasmids were sent to Genewiz, Inc. for 
sequences analysis using primers just upstream of TEV insertion site. 
LR reaction 
An LR reaction was performed to introduce Rpb1-TEV-CTD construct into a 
destination vector with a selective marker: GPD413-HIS3 (Addgene) and GPD415-LEU2 
(Addgene) (Table 4). Fifty nanograms of RPB1-TEV-CTD construct was mixed with 150 
ng of the destination vector and 1 µl of TE buffer (pH 8), followed by the addition of 1x 
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LR Clonase II reaction mix. The reaction mixtures were centrifuged for a minute and 
then incubated overnight at room temperature. After overnight incubation, 1 µl of 
proteinase K solution was added to the reaction mixtures with vortex mixed to terminate 
the reaction and then incubated at 37 °C for 10 minutes. One microliter of each reaction 
mixture was transformed to TOP 10 cells by heat shock for 30 seconds at 42°C. After 
heat shock transformation, 250 µl of S.O.C. media was added to the transformed cells 
followed by incubation at 37 °C for an hour with shaking. The transformed cells were 
spread onto LB- ampicillin plates and incubated overnight at 37 °C. In the following day, 
cells from the plates were inoculated in two separate flasks of 3 ml LB-ampicillin media 
and grown overnight at 37 °C with shaking. The next day, the plasmids were purified 
using QIAPrep spin miniprep kit (Qiagen, Catalog # 27106) and then they were sent to 
Genewiz, Inc. for further sequences analysis. 
Introduce TEV site at amino acid 1460 into RPB1 linker region 
To investigate the optimal CTD cleavage location, we introduced TEV site at 
amino acid 1460 into Rpb1 linker region using RPB1-template (Table 4) and RPB1-TEV-
1460 forward and reverse primers (Table 3). TEV insertion reaction and LR reaction 
described above were repeated in this experiment. TEV insertion was confirmed by DNA 
sequence analysis (Genewiz) using a primer to the RPB1 gene. 
Construction of RPB1-3C-CTD Plasmid 
To examine the cleavage specificity of 3C protease and TEV protease at their 
cleavage sites we introduced 3C cleavage site into Rpb1 linker region at amino acid 1460 
using RPB1-template (Table 4) and RPB1-3C-CTD forward and reverse primers (Table 
3).  3C insertion was confirmed by DNA sequences analysis as outlined above. 
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Table 3. List of primers used in construction yeast S. cerevisiae strains. 
*The insertion sequences (TEV site and 3C site) are in the bold font. 
 
III. Construction of Yeast Strains 
Yeast Transformation 
To introduce RPB1-TEV construct into yeast strain that express a wild type Rpb1  
Primer                            Sequences
*                                                                                                     
Tm°C   
RPB1-TEV-1511 (F)        5´-GCTGGAGGATTTACAGCGTACGAGAATTT 
       GTATTTTCAGGGTGGTGGTGCTGATTATGG 
       TGAAGCCACGTCTCCATTTGGTGCTTATGGT 
       GAAGCACCTACATCTCCCGGATTTGGAGTCT 
       CC-3´ 
  
71.9 
RPB1-TEV-1511 (R)     5´-TTCACCATAATCAGCACCACCACCCTGAA 
    AATACAAATTCTCGTACGCTGTAAATCCTC 
      CAGCCATAGCGTCATTTGAACCCGAATCAAC 
      CAGAGGTGAAAACATTAGCTCATCTTTAACG 
      TC-3´ 
  
71.5 
RPB1-TEV-1460 (F)       5´-TGAGGAGTCACTGGTAAAATACATGCCAG 
      AACAAAAAATAGAGAATTTGTATTTTCAGG 
      GTACTGAGATTGAAGACGGACAAGATGGTGG 
    CGTCACACCAT-3´ 
   
70.7 
RPB1-TEV-1460 (R)        5´-ATGGTGTGACGCCACCATCTTGTCCGTCT 
      TCAATCTCAGTACCCTGAAAATACAAATTC 
      TCTATTTTTTGTTCTGGCATGTATTTTACCAG 
      TGACTCCTCA-3´ 
   
70.7 
RPB1-3C-CTD (F)       5´-TTTGATGTGATGATCGATGAGGAGTCACT 
       GGTAAAATACATGCCAGAACAAAAAATATT 
       GGAGGTTTTGTTTCAGGGACCTACTGAGAT 
       TGAAGACGGACAAGATGGTGGCGTCACACC 
       A-3´ 
  
69.1 
RPB1-3C-CTD (R)          5´-TGGTGTGACGCCACCATCTTGTCCGTCTT 
       CAATCTCAGTAGGTCCCTGAAACAAAACC 
       TCCAATATTTTTTGTTCTGGCATGTATTTTA 
  CCAGTGACTCCTCATCGATCATCACATCAAA-3´ 
  
67.8 
RPB3-TAP (F)       5´- CCTTACTCCAATGCATCTCAAATGGGTA 
  ATACTGGATCAGGAGGGTATGATAATGCTT 
       GGTCCATGGAAAAGAGAAG-3´ 
69.1 
RPB3-TAP (R)       5´- TTCTCTTATTATTTTCGGTTCGTTCACTTG 
    TTTTTTTTCCTC TATTACGCC CACTTGAGAA 
       TACGACTCACTATAGGG-3´ 
67.8 
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gene from a plasmid (the native RPB1 gene was deleted with a CLONAT resistance 
cassette) using standard lithium acetate transformation method, cells from RPB1 GPD 
URA3 strain (Table 4) were inoculated in 25 ml of YPD media and grown at 30 °C 
overnight. Cells were collected by centrifugation at 4 °C after reaching OD600 ~ 0.5, they 
were washed with 1 ml of sterile water and then cell pellets were re-suspended with 500 
µl of TE-LiAc solution. The yeast transformation reaction was prepared by mixing 5 µl 
of 10 mg/ml of single stranded carrier DNA (Sigma-Aldrich, catalog # D7656-1ML), 500 
ng of the RPB1-TEV-CTD plasmid and 100 µl of cell suspension. Subsequently, 600 µl 
of PEG-LiAC solution was added to transformation reaction followed by vortex mixing. 
The transformed cells were incubated at 42 °C for 30 minutes. Following the incubation, 
cells were spin down for few seconds and cell pellets were re-suspended with 200 µl of 
sterile water. The cells were plated in the appropriate selective plates: YNB-His
-
 Ura
-
 
plate
, 
or YNB-Leu
-
 Ura
-
 plate. The plates were incubated at 30 °C for 4 days. 
5-Fluoroorotic Acid (5-FOA) Selection 
5-fluoroorotic acid (5-FOA) was used to select for yeast strains that express the 
modified RPB1 gene (Rpb1-TEV-CTD) and to evict the WT RPB1 URA3 plasmid. Six 
single colonies of the yeast strains that were grown in the plates above were isolated and 
re-streaked each onto their appropriate plates YNB-His
-
 Ura
-
 plate or YNB-Leu
-
 Ura
-
 
plate to obtain single uniformly white colonies and incubated at 30 °C to grow for 2 days. 
After the cells grew, they were re-streaked onto replica 5-FOA plates and incubated at 30 
°C for 2 days. Resulting the 5-FOA resistant colonies were re-streaked onto YNB-His
-
 
Ura
-
 plate or YNB-Leu
-
 Ura,
-
 plate to test if they lost their ability to grow in media 
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lacking uracil. In addition, same colonies were re-streaked onto YNB-His
-
 or YNB-Leu
-
 
to confirm their ability to grow in media lacking histidine and leucine. 
Tagging Yeast Strains with Rpb3-3C-TAP Tag 
PCR Reaction 
Plasmid containing 3C-TAP-URA3 cassette gene (Mosley lab) was amplified by 
PCR using RPB3-TAP primer pair (Table 3). PCR reaction mixtures (100 µl) contained 
100 pg of RPB3-3C-TAP plasmid, 0.3 mM of dNTP mix, 0.3 mM of primer each, 10 µl 
of pfx50 PCR mix, and 5 units of pfx50 DNA polymerase. PCR amplification was carried 
out as follows: initial denaturation at 94 °C for 2 minutes, 35 cycles of denaturation at 94 
°C for 30 seconds, annealing 52 °C for 30 seconds, and extension at 68 °C for 3 minutes. 
The PCR reaction was completed with final extension at 68 °C for 5 minutes. Following 
the amplification, PCR product was mixed with DNA loading dye and was loaded onto 
1% agarose gel containing ethidium bromide, 8 µl of DNA ladder (Thermo Scientific) 
was loaded alongside the PCR product. The gel was run at 100 V in 1x TBE buffer until 
the dye line was 80% down the gel. DNA bands were visualized with ChemiDoc 
molecular imaging system (Bio-Rad). Subsequently, DNA bands were excised and 
purified using QlAquick gel extraction kit (Qiagen, Catalog #28704) and then quantified 
using spectrophotometer. 
Yeast Transformation 
Two micrograms of PCR product obtained in the above step was transferred to 
RPB1-TEV-CTD strains (constructed in section II) using Lithium acetate transformation 
method. Briefly, yeast strain was cultured in 30 ml YPD media and grown to OD600 ~ 0.5. 
Cells were collected by centrifugation at 4°C and were re-suspended with 500 µl of TE-
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LiAc solution. Transformation reaction was prepared similar as in section II.  After the 
incubation of transformed cells at 42 °C for 30 minutes, cells were incubated overnight at 
4 °C to increase transformation efficiency. In the next day, the cells were spin down for 
30 seconds, the supernatant was removed and the cell pellets were re-suspended with 200 
µl of sterile water. And then the transformed cells were plated onto YNB-Leu
-
 Ura
-
 plate
 
or YNB-His
-
 Ura
-
 plate. Cells were incubated at 30 °C for 4 days. 
Western-Blot 
Yeast Strains: Rpb3-3C-TAP Rpb1-TEV-CTD (constructed above), BY4741 (Open 
Biosystems), and Rpb3-TAP (Mosley lab) were inoculated each in 30 ml of YPD media 
and grown overnight at 30 °C. In the next day, cells were pelleted with centrifugation at 4 
°C and then washed with sterile water. Cell pellets were re-suspended with TAP lysis 
buffer and they were lysed with glass beads on a disruptor genie for 30 minutes at 4°C 
and then the lysates were clarified at 14,000 RPM at 4 °C for 30 minutes. A 30 µl aliquot 
of each prepared lysates was mixed with same volume of 2x Laemmli loading buffer with 
BME (Bio-Rad, catalog # 161-0731), and the mixture was subjected to denaturation by 
boiling for five minutes at 100 °C. The denatured samples were loaded onto 12% SDS 
polyacrylamide gel alongside 5 µl of Precision Plus Protein Dual Color Standard 
molecular weight marker (Bio-Rad, catalog #161-0374). The gel was electrophoresed in 
1x Tris-Gly-SDS (TGS) buffer at 200 V until the dye front reached the bottom of the gel. 
The proteins were transferred from the gel to nitrocellulose membrane in a wet transfer 
conditions overnight at 30 V. After overnight transferring, non- specific protein binding 
to the nitrocellulose membrane was prevented by blocking with 5% milk in 1x TBS 
buffer for 45 minutes. Subsequently, the membrane was probed overnight at 4 °C with 
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anti-TAP polyclonal primary antibody (Thermo, 1:1000 diltuion). After overnight 
incubation, the membrane was washed three times with 1x Tris-buffered saline (TBS) (10 
minutes each). And then the membrane was incubated with anti-rabbit IgG horseradish 
peroxidase secondary antibody (GE Healthcare, 1:5000 dilution). After incubation with 
secondary antibody the membrane was washed three times with 1x TBS buffer (10 
minutes each). Proteins were visualized ECL (GE Healthcare) and were detected using 
Fujfilm imager FLA-5000 at 473 nm and the LBP blue filter. 
Table 4. List of plasmids and yeast strains used or constructed in construction of Rpb1-
TEV-CTD strains. 
Plasmid   Description Source or reference 
RPB1-template  RPB1-PENTR-D TOPO Mosley Lab 
RPB1-TEV construct  RPB1-TEV-CTD  This work 
pAG413GAL-ccdB  GPD413-HIS3 Addgene 
pAG415-ccdB  GPD415-LEU2 Addgene 
RPB1GPD415-LEU2  RPB1-TEV-CTD-LEU2 This work 
RPB1GPD413-HIS3  RPB1-TEV-CTD-HIS3 This work 
pBS159 with 3C-TAP  pBS159 with 3C-TAP Mosley lab 
Yeast Strain  Description Source or reference 
BY4741  MATa HIS3-1 LEU2-0 
met1-50 URA3-0  
Open Biosystems 
RPB1 GPD URA3 
 
  MATa HIS3-1 LEU2-0 
met1-50 URA3-0 
[pAG416-URA3-RPB1] 
rpb1::CLONAT 
Mosley lab 
Rpb1-TEV-CTD HIS3 
 
 MATa HIS3Δ1LEU2 Δ 0 
met15Δ0 URA3Δ0 
 [p RPB1-TEV-CTD-
HIS3] rpb1::CLONAT 
This work 
Rpb1-TEV-CTD LEU2  MATa HIS3Δ1LEU2 Δ 0 
met15Δ0 URA3Δ0 
 [p RPB1-TEV-CTD-
LEU2] rpb1::CLONAT 
This work 
Rpb3-3C-TAP Rpb1-
TEV-CTD 
 MATa HIS3Δ1LEU2 Δ 0 
met15Δ0 URA3Δ0 
This work 
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IV. Tandem Affinity Purification (TAP) of Rpb3-3C-TAP Rpb1-TEV-CTD  
Yeast Cell extract 
Rpb3-3C-TAP Rpb1-TEV-CTD strain (Table 4) was cultured in 6 liters of YPD 
media and grown at 30 °C to OD600 ~ 2.5. Cell pellets were collected by centrifugation at 
4°C, washed with sterile water, and re-suspended with TAP lysis buffer (1 to 10 of cells 
to lysis buffer). The cell extract mixture (250 ml) was transferred to stainless steel bead 
beating chamber, and then glass beads were added to the chamber until the mixture 
reached to the top of the chamber. Cell extract was lysed by bead beating in the stainless 
steel chamber surrounded by an ice bath in one minute on and off cycles for 30 minutes. 
Subsequently, the cell lysate was treated with 100 units of DNAse and 300 µg of heparin 
sulfate for 10 minutes to solubilize chromatin (Mosley et al., 2009). After solubilzation, 
cell lysate was cleared by centrifugation for an hour at 4°C, and then the supernatant was 
transferred to a 100 ml glass beaker to proceed with affinity purification.  
Purification I 
Purification I was conducting following the steps illustrated in Figure 4A. An 
aliquot of IgG beads (500 µl) was washed with TAP lysis buffer and then the beads were 
re-suspended with 500 µl of TAP lysis buffer. The 500 µl of IgG beads were added to the 
cell lysate and incubated overnight at 4°C on stir plate. In the following day, cell lysate 
was transferred to a 30 ml Bio-Rad Econoprep column and drained by gravity flow. The 
beads were washed with 30 ml of TAP lysis buffer followed by washing with 3 ml of 
 [p RPB1-TEV-CTD-
LEU2] Rpb3::3C-TAP 
rpb1::CLONAT 
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TEV cleavage buffer. Subsequently, IgG beads were re-suspended in 1 ml TEV cleavage 
buffer and transferred to a new 1.5 ml centrifuge tube. The beads were treated with 10 µl 
of AcTEV protease (Invitrogen) and incubated overnight at 4°C on the rotating wheel.  
After overnight cleavage, the cell suspension-beads mixture was transferred to the same 
column to elute TEV cleaved product by gravity flow, TEV elution presumably has CTD 
and its associated proteins. The retained beads in the column were washed with 5 ml of 
3C cleavage buffer. After washing step, the beads were re-suspended with 1 ml of 3C 
cleavage buffer and were transferred to 1.5 ml centrifuge tube. The beads were treated 
with 10 µl of Prescission 3C protease (GE Healthcare) and incubated over night at 4 °C 
on the rotating wheel. Following overnight cleavage, the cell-beads mixture was 
transferred into the same column and the 3C elution was collected in 15 ml conical tube. 
The beads were washed with 3 ml of calmodulin binding buffer and the flow through was 
collected into the same 15 ml conical tube followed by the addition of 3 µl of 1M CaCl2 
to 3C elution in the 15 ml conical tube to allow the binding of CBP protein to the beads. 
An aliquot of calmodulin sepharose resins (500 µl) was washed with calmodulin binding 
buffer and were re-suspended with 500 µl of calmodulin binding buffer.  Calmodulin 
sepharose (500 µl, Agilent) was added to 3C elution and incubated for 5 hours at 4°C on 
the rotating wheel. Following the incubation, 3C elution-resins mixture was transferred to 
a new Bio-Rad 30 ml Econoprep column and the flow through was drained by gravity 
flow. After washing the column with 30 ml of calmodulin binding buffer, RNAPII 
subunits and the associated proteins were eluted by incubated the column for 5 minutes 
with 500 µl of calmodulin elution buffer with EGTA to chelate CaCl2, then drained by 
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gravity flow. The elutions were collected in 1.5 ml centrifuge tube, the step was repeated 
for 6 times to collect 6 elutions numbered E1-E6. 
Silver Nitrate Stain Analysis of Purification I Calmodulin Elutions 
Prior to the silver nitrate stained SDS-PAGE analysis, calmodulin elutions (E1-
E6) obtained in purification I were TCA precipitation in order to concentrate the proteins 
(see section V for detailed TCA precipitation procedure).  The precipitated samples were 
treated with 8 M urea in 100mM Tris-HCl and then 5% aliquot of each urea treated 
samples was mixed with 2x loading buffer and then boiled for 5 minutes at 100 °C. The 
samples were loaded onto pre-cast SDS-PAGE gel (Bio-Rad) and the gel was run in 1x 
Tris-Gly-SDS buffer at 200 V until the dye front reached the bottom of the gel. Following 
SDS-PAGE separation, the gel was incubated with 100 ml fixing solution overnight to 
improve the sensitivity of the staining and to restrict the movement of the proteins out of 
the gel.  In the next day, the gel was washed with 100 ml methanol wash for 10 minutes 
followed by washing with 100 ml MilliQ water for 10 minutes. After water wash, the gel 
was incubated with 100 ml of sensitizer solution for 10 minutes and then washed with 
100 ml MilliQ water for 10 minutes. Succeeding water wash, the gel was incubated with 
100 ml of silver nitrate solution for 10 minutes followed by washing with 100 ml MilliQ 
water for 5 minutes. One hundred milliliters of developer solution was added to the gel 
and the developing reaction was stopped with 100 ml of the stopping solution when the 
protein bands reached the desired intensity. The developed gel was imaged using Epson 
perfection V700 photo scanner. 
Purification II 
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Purification II was conducting following the steps illustrated in Figure 4B. In this 
purification, the clarified cell extract was treated with 500 µl of IgG beads and incubated 
overnight at 4°C on stir plate. In the following day, cell-beads mixture was transferred to 
a 30 ml Bio-Rad Econoprep column and was drained by gravity flow. After extensive 
washing with TAP lysis buffer, the beads were washed with 3 ml of 3C cleavage buffer. 
Subsequently, IgG beads were re-suspended in 1 ml 3C cleavage buffer, transferred to 1.5 
ml centrifuge tube and then they were treated with 10 µl of prescission 3C protease and 
incubated over night at 4 °C on the rotating wheel.  After overnight cleavage, the mixture 
was transferred to the same column and the 3C cleaved product was allowed to drain by 
gravity flow and was collected in 15 ml conical tube. The beads remaining in the column 
were washed with 4 ml of calmodulin binding buffer and the flow through was collected 
in the same 15 ml conical tube. After the addition of 3 µl of 1M CaCl2 to 3C elution in 
the 15 ml conical tube, a 500 µl aliquot of calmodulin sepharose resins was washed with 
calmodulin binding buffer and was re-suspended with 500 µl of calmodulin binding 
buffer. Subsequently, the calmodulin sepharose resins were added to 3C elution and 
incubated overnight at 4°C on the rotating wheel. Following overnight incubation, the 3C 
elution-calmodulin resins mixture was transferred to a new 30 ml Bio-Rad Econoprep 
column and the buffer was drained by gravity flow. After extensive wash of the resins 
with calmodulin binding buffer, they were re-suspended with 1 ml of CTD cleavage 
buffer and the mixture was transferred to 1.5 ml centrifuge tube. And then the mixture 
was treated with 10 µl of AcTEV protease (Invitrogen) and incubated for overnight 
cleavage at 4 °C. In the next day, the mixture was returned to the same column and TEV 
cleaved product was allowed to drain by gravity and was collected in separate 1.5 ml 
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centrifuge tube, the resins were washed with 1 ml of calmodulin binding buffer and the 
wash was collected in another centrifuge tube. TEV elutions were stored in -80 ° prior 
MudPIT analysis. The remaining resins in the column were washed with 30 ml of 
calmodulin binding buffer and then RNAPII subunits and the associated proteins were 
eluted from the column using calmodulin elution buffer with EGTA to chelate CaCl2. The 
elution was performed as following: the resins in the column were incubated for 5 
minutes with 500 µl of calmodulin elution buffer, the elution was drained by gravity flow 
and collected in 1.5 ml centrifuge tube. The elution step was repeated for 5 times to 
collect 5 elutions numbered E1-E5. 
Silver Nitrate Stain Analysis of Purification II Calmodulin Elutions and CTD Flow-
through 
SDS-PAGE silver stained procedure was performed in order to detect the proteins 
purified in purification II and the CTD elutions from both purifications. Concisely, an 
aliquot (20 µl) of calmodulin elutions (E1-E5) obtained in purification II, CTD elutions 
obtained from both purification was mixed each with 20 µl of 2x loading buffer and then 
denatured for 5 minutes at 100 °C. After denaturation, the samples were loaded onto pre-
cast SDS-PAGE gel (Bio-Rad) and the gel was run in 1x Tris-Gly-SDS buffer at 100 V 
for an hour. Subsequently, the gel was fixed with fixing solution (100 ml) overnight. 
After extensive wash of the gel with methanol and MilliQ water wash (10 minutes each), 
the gel was incubated with sensitizer solution (100 ml) for 10 minutes followed by 
another 10 minutes round of MilliQ water wash. The gel was treated with 100 ml of 
silver nitrate solution for 10 minutes followed by gentle wash with MilliQ water for 5 
minutes. The gel was then transferred to the developing solution (100 ml) and the 
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staining was stopped with 100 ml of stopping solution after the protein bands reached the 
desired intensity. The proteins bands were imaged using Epson perfection V700 photo 
scanner. 
Western-Blot to Examine the CTD Cleavage 
To confirm that TEV protease cleaved CTD from RNAPII, western-blot analysis 
was performed using calmodulin elutions 1 to 5 (Purification II), CTD elutions obtained 
from both purifications. Briefly, an aliquot of each sample was mixed with same volume 
of 2x Laemmli loading buffer with BME (Bio-Rad); the mixture was denatured at 100 °C 
for five minutes. The denatured samples were loaded onto 12% SDS polyacrylamide gel 
alongside 5 µl of Precision Plus Protein Dual Color Standard molecular weight marker 
(Bio-Rad). The proteins were separated by electrophoresis in 1x Tris-Gly-SDS (TGS) 
buffer at 200 V and then they were transferred from the gel to nitrocellulose membrane at 
30 V overnight. Following overnight transferring, the nitrocellulose membrane was 
blocked with 5% milk in 1x TBS buffer for 45 minutes, and then the membrane was 
probed overnight at 4 °C with anti- mouse-H14 monoclonal primary antibody which 
recognizes the phosphorylated serine 5 version of RNAPII (Covance, 1:1000 dilution). 
The next day, the membrane was washed three times with 1x TBS buffer (10 minutes 
each) followed by incubation for an hour at room temperature with anti-mouse-IgM 
secondary antibody (Sigma, 1:5000 dilution). After incubation with secondary antibody 
the membrane was washed three times with 1x TBS buffer (10 minutes each). 
Subsequently, the proteins were visualized using ECL (GE Healthcare) and were imaged 
using Fujfilm imager FLA-5000 at 473 nm and the LBP blue filter. 
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In order to detect the cleavage of 3C-TAP tag in the samples, western-blot 
procedure conducted above was repeated using same set of the samples except probing 
the samples with anti-TAP polyclonal primary antibody (Thermo, 1:1000 dilution) and 
anti-rabbit IgG horseradish peroxidase secondary antibody (GE Healthcare, 1:5000 
dilution). 
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Figure 4.  A schematic representation of the modified TAP purification used to isolate the 
CTD of RNAPII. A. An overview of purification I scheme: in this purification CTD was 
cleaved on-bead by TEV protease while RNAPII complex was immobilized on IgG 
beads. B. An overview of purification II scheme: in this purification CTD was cleaved 
on-bead while RNAPII complex was immobilized on calmodulin beads.  
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The MudPIT protocol performed in this work (Figure 5) was based on the original 
MudPIT protocol (Florens and Washburn, 2006).  
Preparation of the samples 
Two hundreds microliters of the elutions obtained from the purifications 
performed in the previous section was mixed each with 200 µl of 100mM Tris-HCl (pH 
8) and 100 µl of trichloroacetic acid. Following vortex mixing, the samples were 
incubated overnight at 4 °C for TCA precipitation. The following day, the samples were 
centrifuged for 30 minutes at 4 °C at 14,000 RPM. The supernatant was discarded and the 
pellets were washed with acetone cold (500 µl) at 4 °C at 14000 rpm, acetone wash was 
repeated twice. After the wash, the acetone wash was removed and any remaining 
acetone was let to evaporate in speed vac. Subsequently, 8 M urea in 100mM Tris-HCl 
and 5mM of TCEP was added to the precipitated proteins for protein denaturation and 
reduction, and then the samples were incubated for 30 minutes at room temperature. 
Following protein denaturation and reduction, 10mM chloroacetamide (CAM) was added 
to the samples for protein alkylation and the samples were incubated in dark for 30 
minutes at room temperature. Following the incubation, the denatured, reduced and 
carboxy methylated samples were treated with 0.3 µg of endoproteinase LysC and 
incubated overnight at 37 °C with shaking. After overnight digestion, 100mM Tris-HCl 
(pH 8) was added to the samples to dilute the urea to 2 M followed by addition of 2mM 
of CaCl2. 0.5 µg trypsin cold was added to the samples and then the samples were 
incubated at 37 °C with shaking for overnight digestion. In the next day, the digestion 
reaction was quenched with 5% formic acid and the samples were stored at -80 prior to 
MudPIT analysis.  
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Microcapillary Column Packing and Sample Loading 
Microcapillary column was packed in three-phase using pressurization vessel as 
previously described (Florens and Washburn, 2006; McDonald et al., 2002), the column 
was packed in the following order:  8 cm Aqua C18 reverse phase (RP) (Phenomenex), 
followed by 2.5 cm strong cation exchange (SCX)(Phenomenex), and finally with 2 cm 
reverse phase (RP). Following washing the packed column with methanol for 10 minutes, 
the column was equilibrated with buffer A for 30 minutes. Prior to loading the sample in 
the column, the sample was centrifuged at 14,000 for 30 minutes to clarify the sample 
from any particles. And then the sample was loaded overnight into the column. The 
following day, the column was washed with buffer A until it was transferred to a 
Nanoflex nanospray source in-line with a Velos Pro ion trap mass spectrometer 
(Thermo). This process was repeated for all the samples obtained from the two 
purifications described in the previous section. 
High Pressure Liquid Chromatography, Tandem Mass Spectrometry and Database 
Search 
The packed, loaded and washed column was placed in-line with prexeon nano- 
liquid chromatography. And then the sample was subjected to 10-MudPIT analysis as 
previously described (Washburn et al., 2001). Subsequently, the chromatography data 
was eluted in LTQ- Velos Pro ion trap for mass spectrometer analysis.  Following mass 
spectrometer analysis, the tandem spectra (MS/MS) were searched in SEQUEST 
algorithm using Proteome Discoverer 1.3 version (Thermo). In SEQUEST search engine 
the following parameters were selected: MS/MS tolerance 0.8 Da, peptide tolerance 1.4 
dalton, static modifications +57 dalton on cysteine to account for carbamidomethylation 
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from CAM (alkylation), and dynamic modifications + 16 dalton on methionine to account 
for oxidation. The spectra were searched against FASTA database containing 5819 S. 
cerevisiae protein sequences from National Center for Biotechnology Information 
(NBCI) and 281 common contaminated proteins including human keratins, 
immunoglobins and proteolytic enzymes.  In the data analysis, high confidence peptide 
was chosen to calculate for false discovery rate (FDR), which was kept equal to 1% or 
less in all the analysis performed in this work. 
 
Figure 5.  A schematic representation of MudPIT analysis. In this protocol: proteins are 
subjected to enzymatic digestion and then the sample is loaded into three-phase column 
(RP/SCX/RP), the column is transferred to LC/MS, proteins are fractionated and sprayed 
into mass spectrometer, spectra are recorded and then are searched against FASTA 
database. 
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RESULTS 
 
I. Construction of Rpb1-TEV-CTD Plasmids 
The C-terminal domain (CTD) of the largest subunit of RNAPII acts as a platform 
in cooperating the binding of transcription factors and accessories proteins involved in 
transcription, mRNA processing and chromatin modification. In order to develop a 
method to selectively isolate the CTD of RNAPII and its binding proteins for proteomics 
analysis, we inserted the seven amino acids of TEV protease cleavage site (ENLYFGQG) 
into the unstructured linker region of Rpb1 gene using a modified QuickChange site-
directed mutagenesis PCR-based method. QuickChange II XL site- directed mutagenesis 
PCR-based method developed by Agilent Technologies (Santa Clara, CA) works by 
utilizing supercoiled DNA plasmid contains gene of interest as a template and pair of 
complementary primers with the desired mutation (TEV site insert in our experiment). 
Annealing of the mutant primers to DNA template and the extending of the mutant 
primers by PfuUltra high fidelity DNA polymerase produces double strand mutant PCR 
product with a staggered nicks (Figure 6B).  The PCR product is then treated with Dpn 1 
endonuclease to selectively digest the methylated (parental DNA template) and hemi-
methylated (parental-mutant template) to increase transformation efficiency. 
Subsequently, the un-methylated mutant nicked PCR product is transformed into 
ultracompetent cells for nick ligation (Figure 6B). Despite that QuickChange PCR- based 
mutagenesis method is a powerful tool in modifying gene sequences in molecular biology 
studies, the procedure has some limitations that could impact the mutagenesis efficiency 
for example the method is restricted with using complementary synthetic oligonucleotide  
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primers of 25-45 bases in length with melting temperature of Tm ≥ 78°C and the mutation 
should be in the middle of the primers. Using complementary primers in PCR-based 
mutagenesis reaction could result in a low mutation efficiency especially when 
introducing multiple or large mutations because the probability for primers to overlap and 
self- annealing is high, therefore primer-dimer formation becomes more favorable than 
primer-template formation (Wang and Malcolm, 1999). 
 
 
Figure 6.  An overview of QuickChange site-directed mutagenesis PCR-based method.  
A. A diagram of the new primer pair design, TEV insertion is placed in the middle of 5ʹ 
complementary region. B. A scheme of QuickChange three steps: synthesis of mutant 
strands by PCR, digestion of parental templates by Dpn1, and transformation of mutant 
plasmids into ultracompetent cells. 
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In the beginning of our TEV insertion experiment following QuickChange site- 
directed mutagenesis protocol we encountered problems in inserting the TEV cleavage 
site (21 bases in length) (Figure 7A) into RPB1-HIS3 template (size = 12019 bases) due 
to several reasons such as the large size of DNA template we initially used in the reaction 
and the difficulties of satisfying QuickChange primers’ requirements described above for 
instance: primers length and melting temperature. After performing several unsuccessful 
troubleshooting attempts of increasing DNA concentrations and optimizing PCR thermal 
cycle parameters, we eventually were able to generate RPB1-TEV construct following a 
modified QuickChange method developed by Liu and Naismith, 2008. In this method, 
Liu and Naismith designed a primer pair with complementary (overlapping) sequences at 
5ʹ end and larger non-overlapping sequences at 3ʹ end. They constructed various 
mutations including insertion of 18 bases and deletions of 21 bases using their new 
primer design and QuickChange PCR-based mutagenesis method (Liu and Naismith, 
2008). Based on Liu and Naismith developed method, we designed a primer pair with 
complementary sequences at 5ʹ end and larger non-overlapping sequences at 3ʹ end, TEV 
insertion site was placed in the middle of the complementary region (Figure 6A). Using 
the newly designed primers (Tm 71.9°C) and a smaller DNA template (RPB1-template: 
7801 bases) we were able to introduce TEV site upstream of CTD with high efficiency; 
all the analyzed colonies had the mutation. The main advantage of using this method was 
reducing the probability of primers self-annealing because the region of non-overlapping 
end of the new primers is long enough to reach and bind to the nick in the newly 
synthesized DNA therefore use it as a template (Liu and Naismith, 2008). In addition, the 
method eliminated the problem associated with introducing the mutation at low GC 
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region. Furthermore, RPB1-TEV construct was cloned into vector with selective markers 
using LR reaction.   
To test the optimal location of CTD cleavage, we generated RPB1-TEV construct, 
which has the TEV site at amino acid 1460 into Rpb1 linker region (Figure 7C)  
TEV and 3C proteases recognize and cleave distinct but closely related sequences 
(See discussion). Therefore to examine the cleavage specificity of both proteases at their 
cleavage sites in our developed method, we generated RPB1-3C-CTD construct (Figure 
7D). 
Please note that only RPB1-TEV-CTD construct with TEV insertion at amino 
acid 1511 was used to conduct the work presented here including: construction of yeast 
strains, tagging the strain with Rpb3-3C-TAP, TAP purification and MudPIT analysis. 
The construct with TEV insertion at amino acid 1460 was used by students at DePauw 
University to generate wild type and mutant yeast strains. The RPB1-3C-CTD construct 
will be used for future analysis by Mosley laboratory. 
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Figure 7.  Construction of RPB1-TEV-CTD plasmids. A. A diagram showing TEV 
cleavage site gene sequence. B and C. ClustalW alignments of the WT RPB1 and RPB1-
TEV-CTD plasmid sequencing data (performed by Genewiz) showing the TEV cleavage 
site insertion at amino acid 1511 and 1460 of RPB1 respectively. D. A diagram showing 
gene sequence of 3C cleavage site. E. ClustalW alignment of the WT RPB1 and RPB1-
TEV-CTD plasmid sequencing data (performed by Genewiz) showing 3C site insertion at 
amino acid 1460 of Rpb1. 
 
II. Construction of Yeast Strains 
The next approach in our developed method was to construct yeast strain bearing 
the modified copy of RPB1 gene (RPB1-TEV-CTD). In order to accomplish that, three 
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experiments were performed. In the first experiment, RPB1 open reading frame in 
BY4741 strain (Table 4) was deleted with cassette carrying CLONAT marker. The 
cassette was obtained by PCR amplification method from the pAG25 plasmid with 
primers had 65 nucleotide homology regions upstream and downstream of RPB1 gene. 
PCR product was transformed into BY4741 strain (Table 4) to replace the native RPB1 
gene with CLONAT cassette by homologous recombination. Since RPB1 is an essential 
gene, BY4741 cells were transformed with a RPB1 containing plasmid driven by a 
glyceraldehyde 3-phosphate dehydrogenase (GPD) promoter that also contained a URA3 
selectable marker (Table 4). Following transformation with the CLONAT cassette, 
rpb1::CLONAT mutant strains were selected on YNB Ura-CLONAT+ plate.  
In the second experiment, Rpb1-TEV construct was transformed into RPB1 GPD 
URA3 by lithium acetate transformation. The strains were selected on YNB-Leu
-
 Ura
-
 
plate
 
or YNB-His
-
 Ura
-
 plate. The third experiment was performing plasmid shuffle using 
5-FOA. 5-FOA is a pyrimidine analogue drug that is commonly used for selection of 
strains borne mutation in URA3 gene. In the cell, 5-FOA is converted by orotate 
phosphoribosyl transferase into 5-fluorotidine monophosphate (5-FOMP). And then, 5-
FOMP is further converted by 5-monophosphate decarboxylase (encoded by URA3 gene) 
to 5-fluorouridine monophosphate (5-FUMP) (Boeke et al., 1984, 1987).  5-FUMP is a 
toxic metabolite that inhibits thymidylate synthase thus blocking pyrimidine synthesis 
and causing cell death (Boeke et al., 1984, 1987). Therefore, mutant cells that lack URA3 
gene are unable to convert 5-FOA to its toxic form and hence are resistant to the drug 
whereas wild type cells are not resistant. In our experiment, we used 5-FOA to select for 
the plasmid harboring RPB1-TEV-CTD construct and evict the WT RPB1 URA3 plasmid 
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(see Figure 8A for the plasmid shuffle scheme). Furthermore, colonies that only were 
able to grow on 5-FOA (Figure 8B) were isolated and used in the preceding section. 
 
 
 
Figure 8. Construction of yeast strains. A. A schematic representation of plasmid shuffle 
selection for RPB1-TEV-CTD strains. B. Growth of the colonies on 0.1% FOA replica 
plate but not on YNB Ura-His- plate. 
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III. Tagging Yeast Strains With Rpb3-3C-TAP Tag 
Plasmid construct containing a 3C-TAP was amplified using PCR method with 
primers had 65 nucleotide homology upstream of the stop codon of Rpb3 and just 
downstream of the Rpb3 gene (this will remove the stop codon in Rpb3 allowing for 
fusion with the 3C-TAP tag). The 3C-TAP tag is consisting of: Calmodulin binding 
peptide (CBP), Protein A, and 3C cleavage site replacing TEV cleavage site. Agarose gel 
electrophoresis of the amplified DNA is shown in Figure 9A. Subsequently, lithium 
acetate yeast transformation method was performed to integrate the PCR product into the 
genome of RPB1-TEV-CTD HIS3 and RPB1-TEV-CTD LEU2 strains in order to replace 
RPB3 wild type gene. Following several unsuccessful troubleshooting attempts of yeast 
transformation, we were able to integrate the PCR product into the strain and obtained 
colonies grown in one of the selective plates. To confirm the presence of 3C-TAP tag, 
chosen colonies from the plate were analyzed by western-blot alongside Rpb3-TAP strain 
as a positive control and BY4741 strain as a negative control using polyclonal antibody 
against TAP tag (Figure 9B). Western-blot analysis confirmed the tagging of our 
constructed strain as shown in Figure 9B.  
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Figure 9.  Tagging yeast strains with Rpb3-3C-TAP. A. DNA image of PCR product 
around 3000 bp. B. Western-blot analysis confirms the presence of the 3C-Tap tag: 
Rpb3-3C-TAP Rpb1-TEV-CTD and Rpb3-TAP (positive control) were detected around 
70 kDa. 
 
 
IV. TAP Purification of Rpb3-3C-TAP RPB1-TEV-CTD  
In our modified TAP purification method for isolating the CTD of Rpb1 and its 
associated proteins we modified the original TAP purification protocol (Rigaut et al., 
1999; Puig et al., 2001). Consequently, we performed purification I as presented in 
Figure 4A scheme. In this purification, cell extract was subjected to first affinity column 
where protein A in TAP tag bound to IgG resins thus immobilizing RNAPII and the 
associated proteins on the beads. And then, we performed on-bead CTD cleavage with 
TEV protease while the RNAPII subunits were immobilized on IgG resins. Subsequently, 
the CTD-less RNAPII subunits were released from IgG through incubation and cleavage 
with 3C protease. The CTD-less RNAPII subunits and their associated proteins were then 
~3000 bp
Rpb3-3C-TAP yeast strain
#1 #2 #3 By4741 Rpb3-TAP
A
B
PCR product of Rpb3-3C-TAP construct
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subjected to second affinity column where calmodulin-binding peptide (CBP) in the tag 
bound to calmodulin sepharose in the presence of calcium ions. Then, EGTA was used to 
elute CTD-less RNAPII subunits and their associated proteins from the calmodulin 
sepharose.  
Calmodulin elutions (E1-E6) obtained in purification I were subjected to TCA 
precipitation in order to concentrate the proteins and then were analyzed by silver stained 
SDS-PAGE gel to detect the proteins and to evaluate the purification yield. Silver 
staining analysis showed that elutions E1 and E2 had the most recovery (Figure 10); the 
remaining elutions E3-6 had low recovery yield (data not shown). Additionally, all the 12 
subunits of RNAPII were detected as shown in Figure 10, which was determined based 
on previous silver staining analysis of RNAPII (Mosley et al., 2011). Moreover, Rpb1 
exists in two forms: hyper-phosphorylated CTD and hypo-phosphorylated CTD, thus, 
migrate differently on SDS-PAGE gel as previously described (Dubois et al., 1997; 
Svejstrup et al., 1997). However, only one form of Rpb1 was detected in silver stained 
gel around 170 kDa (Figure 10). We speculated that the absence of the second Rpb1 form 
could be resulted from the loss of the CTD. 
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Figure 10.  Silver staining SDS-PAGE analysis of purification I. The gel showing the 
detection of RNAPII 12 subunits in calmodulin elutions as indicated in the left of the gel. 
Molecular weight marker (MWM) was loaded in the first lane to the right side of the gel. 
  
CTD elution collected post TEV protease cleavage was analyzed in LC/MS 
reverse phase. The preliminary data we obtained from LC/MS analysis showed that the 
CTD sample was contaminated with RNAPII all twelve subunits (Table 5). These data 
indicated that TEV protease partially cleaved 3C site thus releasing part of RNAPII 
subunits from the IgG resins. 
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Table 5. RNAPII 12 subunits were identified in CTD elution by LC/MS. 
Accession Description Sequence 
Coverage %  
# Peptide # PSMS # AAs MW  
6320061 Rpb1 27.35    37   197 1733 191.5 
398365417 Rpb2    24.02    8   119 1224 138.7 
398364469 Rpb3 56.92    12   43 318 40.3 
6322321 Rpb4 50.68    9   34 221 25.4 
398366567 Rpb7 52.63    6   24 171 19.0 
6324798 Rpb8 43.84    5   23 146 16.5 
6325445 Rpb6 39.35    4   14 155 17.9 
6321368 Rpb9 38.52    2   14 144 14.3 
6319630 Rpb5 27.91    6     13 215 25.1 
398365775 Rpb10 54.29    3     8 144 14.3 
6324569 Rpb11 42.50    3   6 120 13.6 
6321937 Rpb12 28.57    1   5 70 7.7 
 
In order to prevent the cleavage of 3C site by TEV protease, we modified our 
TAP purification protocol as shown in Figure 4B scheme (purification II). In this 
purification, we initially performed 3C protease cleavage and the releasing of RNAPII 
and the associated proteins from the IgG resins. And then, RNAPII subunits and the 
associated proteins were subjected to a second affinity column followed by on bead TEV 
protease cleavage while the RNAPII subunits were immobilized on calmodulin 
sepharose. Subsequently, the CTD-less RNAPII subunits were released from the 
calmodulin sepharose with 2mM EGTA. 
Furthermore, calmodulin elutions (E1-E5) obtained from purification II CTD 
elutions obtained from both purifications were analyzed in silver stained SDS-PAGE to 
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evaluate the purification yield and to examine the CTD cleavage (Figure 11).  Although, 
the purification yield was lower than purification I yield, similar pattern of RNAPII 
subunits were detected in this purification as in the previous purification, for example 
only one form of Rpb1 was detected around 170 kDa corresponded with purification I. In 
addition, protein around 30 kDa was detected in CTD elutions but not in calmodulin 
elutions and would likely be TEV protease. 
 
 
Figure 11. Silver staining SDS-PAGE analysis of purification II. The gel showing 
RNAPII subunits detected in calmodulin elutions as indicated in the right side of the gel. 
CTD elutions (elutions of the CTD that released by TEV protease cleavage) are labeled 
as following: Sample #1 is the CTD elution obtained from purification I. Sample #2 is the 
CTD elution obtained from purification II, and sample #3 is the wash elution collected 
post the elution of the cleaved CTD (purification II). 
 
To further confirm the cleavage of CTD, two western-blot analyses were 
performed. First western-blot was performed to detect the presence of CTD in calmodulin  
elutions and CTD elutions using antibody against phosphorylated CTD (Anti-H14)  
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(Figure 12 top). In western-blot analysis, CTD was observed in CTD elutions (sample #3 
and #1). On the other hand, CTD was not observed in calmodulin elutions (Figure 12 
top). The absence of CTD in calmodulin elution samples indicates that the CTD was 
cleaved from Rpb1 linker region by TEV protease. 
Second western-blot was performed to determine the cleavage of TAP tag in the 
calmodulin elutions as well as to examine if the cleaved tag is present in the CTD 
elutions using polyclonal antibody against TAP tag. Western-blot analysis confirmed the 
presence of CBP-Rpb3 around 50 kDa in calmodulin elutions. Conversely, CBP-Rpb3 
was not identified in the CTD elutions (Figure 12 bottom). These data showed that 
RNAPII subunits were not detected in CTD elutions. 
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Figure 12.  Detection of CTD cleavage by western-blot analysis. Top: western-blot 
analysis with anti-H14 to detect the presence of the CTD in calmodulin elutions and CTD 
elutions. Bottom: western-blot analysis with anti-TAP to detect the presence of cleaved 
TAP tag in calmodulin and CTD elutions. E1-E5 (calmodulin elutions from purification 
II). CTD elutions (elutions of the CTD that released by TEV protease cleavage) are 
labeled as following: Sample #1 is the CTD elution obtained from purification II. Sample 
#2 is the wash elution collected post the elution of the cleaved CTD (purification II), and 
sample #3 is the CTD elution obtained from purification I. 
 
MudPIT Analysis 
Calmodulin elutions and CTD elutions (hereafter referred to as CTD-less RNAPII 
and CTD-associated respectively) obtained from aforementioned purifications were 
analyzed in mass spectrometry using MudPIT method and database search algorithms 
SEQUEST. In CTD-less RNAPII, all the twelve subunits of RNAPII were detected and 
listed in Table 6. A total of twenty-one transcription-relevant proteins were identified in 
CTD-less RNAPII samples with at least one unique peptide detected (Table 7). The 
common TAP purification contaminants in S. cerevisiae and the cytoplasmic ribosomal 
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subunits were excluded from the results as described before (Korgan et al., 2006, 2004). 
Additionally, the proteins that are not transcription-relevant and were detected with at 
least 2 unique peptides and 100 PSMs are also included in (Table 7). 
 
Table 6: RNAPII 12 subunits detected in CTD-less RNAPII samples by MudPIT.  
Accession Description   Sequence 
 Coverage %  
# Peptide # PSMS # AAs MW  
6320061 Rpb1 62.55    112 7108 1733 191.5 
398365417 Rpb2 66.58    105 6412 1224 138.7 
398364469 Rpb3 78.30     25 1502 318 40.3 
6319630 Rpb5 61.86    17 689 215 25.1 
6322321 Rpb4 86.43    18 499 221 25.4 
6324798 Rpb8 44.52    10 379 146 16.5 
6325445 Rpb6 58.71     8 269 155 17.9 
398365775 Rpb10 54.29     4 259 151 8.3 
6321368 Rpb9 61.48    10 237 144 14.3 
6324569 Rpb11 96.67    18 170 120 13.6 
6321937 Rpb12 60.00     4 88 70 7.7 
398366567 Rpb7 55.48     9 50 171 19.0 
 
Table 7. Proteins identified in CTD-less RNAPII samples by MudPIT. 
Accession Description  Sequence 
 Coverage %  
# Peptide # PSMS # AAs MW  
Transcription-relevant proteins 
gi6323632 Spt5p  5.64     7   10 1063 115.6 
gi6321552 Spt6p  5.69     2    7 1451 168.2 
gi39836515
5 
Npa3p  9.35     3    3 385 43.2 
gi39836484 Rtr1p  7.78     2    3 226 26.27 
gi6320041 Dhh1p  7.71     3    3 506 57.5 
gi6321013 Pab1p  6.58     3    3 577 64.3 
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gi6321295 Dst1p  4.21     3    3 309 34.8 
gi6321911 Set1p  1.68        2    3  1080 123.8 
gi6324761        Rap1p   5.26     2     2 433 48.9 
gi37362706        Asr1p  4.86     2     2 288 33.3 
gi63233999        Rpd3p  3.70     2     2 437 47.9 
gi39836603        Pbp1p  3.46     2     2 722 78.79 
gi39836667       Rba50p  3.19     2     2 439 50.29 
gi39836659        Npl3p  3.14     2     2 414 45.41 
gi6323676        Arp9p  2.57     2     2 467 53.0 
gi33044360        Set2p  2.05    2     2 733 84.45 
gi6324879        Isw2p  1.52     2     2 1120 130.2 
gi6323839        Rtp1p  1.12     2     2 981 113.2 
gi39836660        Ada2p  3.00     1     1 434 50.55 
gi39836582       Caf130  1.07     1     1 1122 128.7 
gi10383811       Cdc39  0.57     1     1 2108 240.1 
 Not transcription-relevant proteins 
gi398364951           Vma2p         53.77               35            135             517           57.7 
gi6323278               Yef3p          16.67               26             101            1044         115.9 
gi6324707               Eft1p           16.39               20             99              842            93.2 
 
In CTD-associated, a total of fifty-one transcription-relevant proteins were 
identified with at least one unique peptide detected, the proteins are listed in (Table 8). 
The proteins that are not transcription-relevant and were detected with at least 2 unique 
peptides and 100 PSMs are included in (Table 8). 
 
Table 8. Proteins identified in CTD-associated samples by MudPIT. 
Accession Description  Sequence 
 Coverage %  
# Peptide # PSMS # AAs MW  
Transcription-relevant proteins 
gi6320119 Sub2p   29.70    11 40 577 64.3 
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gi39836659 Npl3p  26.52   12 21 414 45.41 
gi39836667 Rba50p  22.32   12 21 439 50.29 
gi6324761 Rap1p 14.19   8 14 433 48.9 
gi6321013 Pab1p 13.34   8 14 577 64.3 
gi6321295 Dst1p 16.83   7 12 309 34.8 
gi6321333 Arc1p 13.30   6 12 376 42.1 
gi39836515 Npa3p  8.05   5 11 385 43.25 
gi39836484 Rtr1p 13.72   4 7 226 26.27 
gi39836506 Sup45p 8.92   6 7 437 49.01 
gi6323738 Npl6p 6.67   4 6 49.6 4.96 
gi6323632 Spt5p 4.42   4 6 1063 115.6 
gi39836603 Pbp1p 4.29   4 6 722 78.79 
gi6321231 Spt16p 2.8   6 6 1035 118.6 
gi323144 Cft2p 11.71   2 5 859 96.2 
gi6321265 Xrn1p 4.29   5 5 1528 175.3 
gi6321552 Spt6p 2.76   4 5 1451 168.2 
gi6321265 Xrn1p 4.29   5 5 1528 175.3 
gi632089 Snu13p 25.40   3 4 126 13.6 
gi6320041 Dhh1p 10.47   3 4 506 57.5 
gi39865953 Sup35p 4.96   4 4 685 76.5 
gi6324761 Pan2 4.48   4 4 1115 127 
gi6321911 Set1p    2.04   4 4 1080 123.8 
gi6319772 Isw1p  3.01   3 3 1129 131 
gi39836545 Spt4p 18.63   2 2 102 11.27 
gi6324613 Ckb2p 8.91   2 2 258 29.8 
gi6323676 Arp9p 6.85   2 2 467  53 
gi6320589 Yra1p 5.75   1 2 226 24.9 
gi6323336 Pob3p 4.89   2 2 553 63.0 
gi37362669 Ess1p 4.71   2 2 170 19.4 
gi6321625 Tfg1p 3.13   2 2 735 82.1 
gi6314675 Taf5p 3.13   2 2 798 88.9 
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gi6323518 Nab6p 2.82  2 2 1134 126.1 
gi6325028 Cet1p 2.00  2 2 549 61.8 
gi63198890 Taf2p 1.56  2 2 1470 161.4 
gi10383811 Cdc39 1.44  2  2 2108 240.1 
gi6323307 Ysh1p    1.41  2  2 779 87.6 
gi39836582 Caf130 1.07  2  2 1122 128.77 
gi323892 Taf9p 7.64  1  1 157 17.3 
gi39836488 Ckb1p 6.12  1  1 278 32.27 
gi39836592 Taf10p 4.37  1 1 20.6 23.01 
gi6322710 Ctk1p 3.79  1 1 528 60.5 
gi39836491 Spt15p 2.91  1 1 240 27.01 
gi6325291 Arp7p 2.73  1 1 477 53.8 
gi6323524 Ctk3p 2.70  1 1 296 34.8 
gi6323255 Bur2p 2.53  1 1 395 45.7 
gi6325246 Taf3p 2.27  1 1 353 40.3 
gi6321326 Taf6p 2.13  1 1 57.9 5.43 
gi6325066 Nab3p 1.98  1 1 459 51.9 
gi6323572 Taf8p 1.96  1 1 510 40.3 
gi6321012 Chd1p 1.57  1 1 656 75.1 
gi6322334 Spt10p 1.25  1 1 640 72.9 
Not transcription-relevant proteins 
gi6325337            Tef1p            58.73            26               1066            408           50.0 
gi6324707            Eft1p             16.39            20               216              842           93.2 
gi6323278            Yef3p           16.67            26                187             1044         115.9 
gi6324265            Ydj1p           56.23            16                132             409           132 
gi398364951        Vma2p          47.0             35                113             517           57.7 
gi6323013             Tsa1p          48.98            12                103             196           21.6 
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DISCUSSION 
In an effort to advance the methodology in analyzing RNAPII protein-protein 
interaction network and to determine the role of the CTD in controlling RNAPII 
transcription, we devised a method to specifically isolate the CTD-associated and CTD-
less RNAPII to identify the proteins that interact with both the CTD and the globular core 
of RNAPII using novel purification scheme coupled to quantitative proteomics.  
The first approach in this method was placing TEV protease cleavage site at the 
flexible linker region of RNAPII upstream of CTD using a modified site directed 
mutagenesis PCR-based method generating a construct with RPB1-TEV gene (Figure 7). 
Similar Rpb1 modified constructs have been made before to prepare a CTD-less RNAPII 
for in vitro transcription studies (Li and Kornberg, 1993; Nair et al., 2005). The site of 
TEV insertion at the linker region of RPB1 was determined based on crystal structures of 
RNAPII. In the crystal structures, the linker emerges from the RNAPII core below the 
clamp and connects to the CTD of RNAPII as shown in Figure 13. 
Further, the modified Rpb1-TEV gene was introduced in S. cerevsisiae strains 
expressing wild type RPB1 gene from a plasmid (the native RPB1 gene was deleted with 
a CLONAT resistance cassette) to replace the wild type gene using 5-FOA plasmid 
shuffle yielding strains dependent on the modified RPB1-TEV gene for growth (See 
Figure 8 for the plasmid shuffle scheme). The next approach in our method was tagging 
the strain with a modified TAP tag that has TEV cleavage site replaced by 3C cleavage 
site. A plasmid construct expresses the 3C-TAP was amplified by PCR to increase the 
homology region upstream and downstream of RPB3 gene. And then the PCR fragment 
was integrated at the C-terminal of RPB3 gene of the RPB1-TEV strain by homologues 
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recombination. The presence of the 3C-TAP tag was confirmed by western-blot analysis, 
as shown in (Figure 9B), Rpb3-3C-TAP Rpb1-TEV strain and the positive control (Rpb3-
TAP) were detected at ~70 kDa whereas the negative control (BY4741) was not detected. 
  
Figure 13.  A ribbon model of RNAPII showing the linker helix region as visualized upon 
Rpb4/Rpb7 binding. In the right side of the figure a cartoon schematic of the CTD and 
Rpb1 linker helix, linker helix is shown as a dashed line. Figure is adapted from 
(Armache et al., 2003; 2005).  
 
To isolate the CTD-associated and CTD-less RNAPII, we designed a novel TAP 
purification scheme (Figure 3 and 4) by modifying the original TAP protocol (Rigaut et 
al., 1999; Puig et al., 2001) to take advantage of TEV cleavage site upstream of CTD. In 
the modified purification, we performed on-bead cleavage of the CTD using TEV 
protease while the RNAPII and its associated proteins are retained on the IgG beads 
through association with Rpb3-3C-TAP. The CTD-less RNAPII along with the 
associated proteins were released from IgG resins by the action of 3C protease followed 
by incubation with calmodulin resins and the release of the CTD-less RNAPII and the  
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associated proteins with EGTA. The isolated CTD-less RNAPII (calmodulin elutions) 
was analyzed by silver stained SDS-PAGE gel to evaluate the efficiency of our designed 
purification method. The on-bead cleavage of the CTD by TEV protease did not prevent 
RNAPII subunits detection; all the 12 subunits were detected in the silver stained SDS-
PAGE analysis (Figure 10). In previous TAP purification silver staining analysis of wild 
type S. cerevisiae, two forms were observed for Rpb1 subunit corresponded to hyper-
phosphorylated CTD and hypo-phosphorylated CTD (Mosley et al., 2011). Conversely, 
we only observed one form of Rpb1 subunit around 170 kDa we hypothesized that the 
mobility change of the Rpb1subunit on the gel caused by truncation from TEV protease 
cleavage. Additionally, similar CTD-less RNAPII mobility trend on SDS-PAGE was 
observed before (Li and Kornberg, 1993; Nair et al., 2005). 
 In preliminary data from MudPIT analyses of the CTD-associated (CTD elution) 
it was observed that the purification was contaminated with RNAPII subunits, all the 
twelve subunits were detected (Table 5). However, the number of peptide spectra 
matches (PSMs) for the twelve subunits were below the average of detected PSMs values 
of RNAPII subunits purified from wild type S. cerevsisiae as previously observed 
(Mosley et al., 2013). Therefore, we hypothesized that TEV protease cleaved a portion of 
the 3C cleavage sites thus releasing part of RNAPII subunits from the IgG resins. 
In general, the TEV protease recognition site is consisting of seven amino acids 
(ENLYFQG/S) (reviewed in Waugh, 2011). Previous experimental studies 
investigating the specificity of TEV protease have shown a strong preference for glutamic 
acid and tyrosine in the P6 and P3 position respectively and a moderate preference for 
phenylalanine, leucine and asparagine in the P2, P4, P5 position respectively (Daugherty 
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et al., 1989; Carrington et al., 1988). These data lead to define the consensus for TEV 
protease cleavage site as “Glu-Xaa-Xaa-Tyr-Xaa-Gln Ser/Gly” with the assumption 
that Xaa position could be substituted with other residues (Daugherty et al., 1989; 
Carrington et al., 1988). However, recent study has shown that various residues can be 
accommodated in P1ʹ position with little impact on TEV protease cleavage efficiency 
(Kapust et al., 2002). In contrast, the 3C protease recognition site is consisting of eight 
amino acids (LEVLFQPG) where the presence of Gly-Pro dipeptide after the scissile 
bond is restricted (reviewed in Waugh, 2011). Unlike TEV protease, the specificity of 3C 
protease has not been extensively investigated in the literature.  
Consequently, we propose that the specificity tolerance of TEV protease for 
residues in P1ʹ, P2, P4 and P5 positions caused cleavage of a portion of the 3C sites of 
our modified TAP tag. In an attempt to eliminate the cleavage of 3C by TEV protease, we 
revised our purification method (Figure 4B). In the revised purification, we performed 3C 
protease cleavage and the releasing of RNAPII and the associated proteins from the IgG 
resins. Following the incubation of RNAPII subunits with calmodulin resins, TEV 
protease cleavage was performed while the RNAPII subunits were immobilized on 
calmodulin sepharose resin. Subsequently, aliquots of the isolated CTD-less RNAPII and 
CTD-associated were analyzed by SDS-PAGE and visualized with silver staining (Figure 
11). It was noted from SDS-PAGE analysis that purification II yield was significantly 
less than purification I (Figure 11 and 10 respectively). Yet, a similar pattern of RNAPII 
subunits was detected including Rpb1 mobility change on SDS-PAGE. Additionally, we 
observed unique protein in CTD-associated samples around 30 kDa, based on the size of 
the protein we proposed that this protein is TEV protease (Figure 11). The cleaved CTD 
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remnant appears to run as a smear just above the 37 kDa marker and can be detected 
using monoclonal antibodies against the CTD (Figure 12).  
In order to increase the confidence of CTD cleavage, two western-blot analyses 
were performed using second aliquots of the isolated CTD-less RNAPII and CTD-
associated (Figure 12). It was concluded from the first western-blot analysis that the CTD 
was present in CTD-associated samples (#3 and #1) but not in the CTD-less RNAPII 
samples (Figure 12 top). In the second western-blot analysis, the cleaved TAP tag (CBP-
Rpb3) was not observed in CTD-associated samples conversely it was observed in CTD-
less RNAPII samples (Figure 12 bottom). In summary, western-blot data confirmed the 
isolation of CTD from RNAPII. Besides, the data has indicated that the CTD-associate 
samples from purification II were not contaminated with significant amounts of RNAPII 
subunits.  
The last approach in our designed method was analyzing the CTD-less RNAPII 
and CTD-associated samples in mass spectrometry using MudPIT followed by 
quantitative analysis using database search alogrithms SEQUEST through the software 
program proteome Discovere 1.4 (Thermo). It was observed before in (unpublished data 
from Mosley lab) that the native CTD peptides especially in S. cerevisiae are 
undetectable in mass spectrometry analysis due to the lack of basic residues in its primary 
amino acid sequence for trypsin digestion. Therefore, in an attempt to clarify if the 
isolation of CTD through our developed method could be detectable in mass 
spectrometry, MS data was screened for the peptide that was cleaved by TEV protease. 
However, the peptide was not detectable because the region of the Rpb1 linker where the 
TEV site was placed has only one basic lysine residue (Figure 14). In an assumption that 
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trypsin cleaved the peptide bond between lysine and aspartic acid upstream TEV site then 
the resulting peptide is 30-mer which is a suboptimal peptide to be detected by mass 
spectrometry (Figure 14). 
 
Figure 14.  Peptide sequences of Rpb1 subunit of RNAPII detected by MudPIT. 
The sections highlighted in green were identified by MudPIT analysis. The red arrows 
indicate the position of TEV protease cleaved peptide that was not detected by mass 
spectrometry; TEV site is shown in red font. The peptide sequence is: 
DELMFSPLVDSGSNDAMAGGFTAY(ENLYFQ.G).  
  
It was noted that the PSMs values for all the proteins detected in CTD-less 
RNAPII and CTD-associated from purification II were significantly low, we speculated 
that the reason for that was the poor yield of purification II. Therefore, the mass 
spectrometry data presented in Table 7 and 8 were combined from purifications I and II.  
In addition to the 12 subunits of RNAPII, a total of twenty-one transcription-
relevant proteins were detected in CTD-less RNAPII. In CTD-associated a total of fifty-
one transcription- relevant proteins were detected. Some of these proteins were detected 
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in both CTD-associated and CTD-less RNAPII; these proteins are summarized in (Figure 
15) according to the PSMs values. Among these proteins, there were two proteins Spt5 
and Spt6 detected with higher PSMs values in CTD-less RNAPII than CTD-associated. 
Spt5 is a component of elongation factor DSIF (Spt4/spt5) involved in controlling 
transcription elongation whereas Spt6 is an elongation factor involved in nucleosomes 
remolding, Spt5 and Spt6 are essential for growth in S. cerevisiae (Wada et al., 1998). In 
addition, genetic analysis has suggested that Sp5 and Spt6 are functionally related but no 
evidence if they are physically associated (Hartzog et al., 1998). It has been reported 
before that Spt5 is the most enriched RNAPII interacting protein identified in mass 
spectrometry when using one of RNAPII subunits such as Rpb3, Rpb7 or Rpb11 as bait 
for TAP purification (Mosley et al., 2013, 2011). In correlation with this observation, 
Spt5 was detected in both CTD-less RNAPII and CTD-associated. Interestingly, three of 
the low abundance proteins that were hardly detected in mass spectrometry quantitative 
analysis as observed before (Mosley et al., 2013) Set2, Asr1, and Npa3 were detected in 
CTD-less RNAPII. 
A total of nine transcription-relevant proteins were identified in CTD-associated 
with higher PSMs values than in CTD-less RNAPII (Figure 15), among these proteins is 
Dst1. Dst1 (TFIIS) is an elongation factor that is conserved in bacteria and eukaryotes, it 
composes of three domains N-terminal domain I, C-terminal domain II and zinc loop fold 
domain III. Dst1 stimulates the intrinsic transcripts cleavage activity of RNAPII 
following backtracking (reviewed in Fish and Kane, 2002; Matrinez-Rucobo and Cramer, 
2013). RNAPII backtracking is a process of translocation that is involved in transcription 
through difficult nucleosomes and in promoter-proximal pausing. In backtracking, 
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RNAPII moves backward along the elongation complex that leads to the disengagement 
of the 3ʹ end of the transcript from the active site causing a transcription arrest (reviewed 
in Fish and Kane, 2002; Matrinez-Rucobo and Cramer, 2013).  
Structural studies have revealed the mechanism of Dst1 in stimulating RNAPII 
intrinsic cleavage activity and releasing RNAPII from the arrested state. Dst1 binds to 
RNAPII with its C-terminal domain and extending its domain III (zinc ribbon fold) into 
the active site with three charged residues one basic residue and two acidic residues 
(Wang et al., 2009; Cheung and Cramer 2011). The binding of Dst1 to the arrested 
RNAPII stimulates the recruitment of Mg
+2
 ion and water molecule to RNAPII active 
site. Consequently, Dst1 facilitates the alignment of 3ʹ end of the backtracked transcript 
at the active site and promotes the cleavage of phosphodiester bond of the backtracked 
transcript by RNAPII through stabilizing the charged transition state and through 
promoting proton transfer (Wang et al., 2009; Cheung and Cramer 2011).  
In addition to stimulate transcription in vitro, Dst1 was found to stimulate 
transcription past an artificial arrest in vivo (Kulish and Struhl, 2001). Kulish and Stuhl 
designed an assay to analyze transcription elongation in vivo involves an artificial arrest 
site (ARTAR).  Using ARTAR they observed discontinuous in transcription elongation 
and they reported that the transcriptional reactivation is strongly related to Dst1 function 
(Kulish and Struhl, 2001). Interestingly, recent reports suggested that Dst1 contributes to 
transcription initiation beside its role as an elongation factor. Recent study using ChIP 
assay demonstrated a cross-linking of Dst1 and GAL1 activation sequences, it also 
showed that the Dst1 was required for optimal binding of TATA binding protein (TBP) 
and RNAPII to GAL1 promoter (Prather et al., 2005). In addition Dst1 was identified in 
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quantitative mass spectrometry analysis of PIC and that could suggest a role of Dst1 in 
initiation of transcription (Ranish et al., 2003). Yet, there is no direct biochemical 
evidences to support its role during transcription initiation.  
 
Figure 15.  Proteins identified by MudPIT analyses in both CTD-associated and CTD-
less RNAPII following TAP purification. The difference in detection level (number of 
peptide spectra matches) versus the proteins names.  
 
Besides Dst1, there were seven proteins detected in CTD-associated with 
significant difference of PSMs than CTD-less RNAPII (Figure 15), the proteins are Npl3, 
Rab50, Pab1, Pbp1, Npa3, Rap1, and Rtr1. Npl3 (also termed Nob1 and Nop3) is an 
RNA binding protein in S. cerevisiae that exports poly (A) mRNA from the nucleus to 
the cytoplasm, mutation in Npl3 has caused nuclear accumulation of mRNA (Lee et al., 
1996). Rba50 is a protein involved in transcription through interaction with Rpb2, Rpb3  
and Rpb11of RNAPII (Saccharomyces Genome Database: http://www.yeastgenome.org). 
Pab1 binds to poly (A) tail of mRNA and function with other factor to couple 3ʹ end 
processing with mRNA export (Dunn et al., 2005). Pbp1 is a Pab1 binding protein that 
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regulates mRNA polyadenylation (Saccharomyces Genome Database: 
http://www.yeastgenome.org). Npa3 is a cytoplasmic protein important of transporting 
RNAPII into the nucleus, genetic study has shown that depletion of Npa3 results in 
accumulation of RNAPII in the cytoplasm (Staresinic et al., 2011). Npa3 as mentioned 
earlier is a low abundance protein that is usually not detectable in mass spectrometry 
analysis. Rtr1 is a CTD Ser5 phosphatase that regulates the transition of high Ser5-P level 
to high Ser2-P (Mosley et al., 2009). Rap1 is a DNA-binding protein that has dual 
functions either activate or repress transcription (Hardy et al., 1992). 
In addition to the proteins mentioned above, four proteins were detected at the 
same level in CTD-associated and CTD-less RNAPII (Set1, Arp9, Cdc39 and Caf130). 
Set1 is a histone H3-lysine 4 methyltransferase (H3-K4) that recruited to RNAPII at the 
5ʹ end of the coding region. Set 1 interacts with Ser5 phosphorylated CTD form of 
RNAPII but not phosphorylated Ser2 (Ng et al., 2003). Cdc39 and Caf130 are 
components of yeast CCR4-NOT complex that is important for gene regulation during 
the transcription cycle (Saccharomyces Genome Database: http://www.yeastgenome.org). 
 Sub2 a component of TREX complex was detected only in CTD-associated with 
high PSMs value. TREX complex mediates the coupling of mRNA synthesis and the 
nuclear mRNA export (Strasser et al., 2002). TREX complex consists of THO complex 
that interacts with phosphorylated Ser2 and Ser5, and Sub2/Yra1 mRNA export factors. 
ChIP-chip analysis has shown that the occupancy of THO, Sub2 and Yra1increases from 
5ʹ end to 3ʹ end of the gene (Meinel et al 2013). Meinel and colleagues used ChIP-based 
assay with a reporter containing self-cleaving ribozyme, through ChIP data they proposed 
that TREX recruitment to transcription machinery is dependent upon the interaction of 
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THO complex to Ser2-P and Ser5-P and partially RNA dependent. Interestingly, Yra1 
was detected in CTD-associated with a significant lower PSMs value than Sub2.   
Subunits of the general transcription factor TFIID were identified in CTD-
associated sample including Taf2/Taf3/Taf5/Taf6 and Taf8-10. In general, TFIID 
comprises TBP and 13 TBP-associated factors (TAFs). TBP and Taf2/Taf3/Taf8 
recognize and bind to the TATA box at the core promoter prior PIC assembly (reviewed 
in Thomas and Chiang, 2006). Some of the TFIID subunits Taf5/Taf9/Taf10 are present 
in SAGA complex and involved in chromatin modification (Grant et al., 1998). Previous 
studies have shown that mutations in three of TFIID subunits (Taf5, Taf10 and Taf12) 
impact SAGA composition and integrity proposing an important role of these subunits for 
SAGA structure (Durso et al., 2001; Grant et al., 1998).  
Ctk1 and Ctk2 are subunits of CTDK-I the kinase complex that phosphorylates 
Ser2. Both subunits were identified in CTD-associated with only one unique peptide 
identified for each. In addition, the following proteins were identified with only one 
unique peptide for each: Nab3, Chd1, Yra1 and Bur2. Nab3 is an RNA binding protein 
that associates with Nrd1 and Sen1 to form a complex to interact with exosome and 
stimulate RNA degradation activity be exosome (reviewed in Kuehner et al., 2011). The 
function of Nrd1-Nab3 complex is linked to CTD phosphorylation. Increasing of CTD 
Ser2-P phosphorylation by mutation in Fcp1 leads to decrease in Nrd1 complex 
recruitment and termination defects (Gudipati et al., 2008). 
Components of FACT complex were detected in CTD-associated including Sp16 
and Pob3. FACT complex is an elongation factor that interacts specifically with 
nucleosomes and H2A/H2B dimers and facilitates nucleosomes disassembly ahead of 
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RNAPII (Orphanides et al., 1999). It has been proposed that FACT affects transcription 
elongation fidelity by linking initiation to elongation. Mutation in Spt16 results of 
decreased PIC at the promoter complex and suppressed transcription of some of the 
coding genes (Mason and Struhl, 2003). 
In summary, our results have indicated that the devised purification method is an 
efficient method in analyzing RNAPII protein interaction network. Through this method 
we successfully were able to isolate the CTD and CTD-less RNAPII (which has been 
demonstrated by western-blot analyses) without affecting the detection of the 12 subunits 
of RNAPII as was shown in silver stained SDS-PAGE and mass spectrometry analyses. 
In addition through this method we were able to detect various proteins that involved in 
transcription including high abundance proteins such as elongation factors Spt4/Spt5, 
Dst1, components of FACT complex and Spt6. In addition, the low abundance proteins 
that only interact with RNAPII during certain stage in transcription were detected such as 
Asr1, Set2, and Npa3. 
In the modified TAP purification, two purification schemes have been used. In the 
first scheme (Figure 4A), on-bead TEV cleavage of the CTD was performed while the 
RNAPII complex was immobilized on IgG beads. Although this purification scheme 
resulted in good purification yield as well as good detection level of RNAPII interacting 
proteins by MudPIT analyses, the isolated CTD-associated was contaminated with 
RNAPII subunits as discussed earlier. This limitation could be overcome by incubating 
the CTD supernatant following TEV cleavage with calmodulin beads to remove the 
contaminant and ensure that the RNAPII subunits are cleared from the CTD-associated 
sample or by scaling up the starting amount of protein for RNAPII isolation. 
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Another approach to specifically isolate the CTD and eliminate the cleavage of 
3C site by TEV protease is to perform the CTD cleavage with 3C protease rather than 
TEV protease. As been demonstrated with our data, 3C is more specific and more 
restricted for cleaving its site than TEV protease. Therefore, a suggested future path is to 
use the Rpb1-3C-CTD construct that was generated through this work (Figure 7E) to 
construct yeast strains express Rpb1-3C-CTD gene and tagged with the original TAP tag 
or a 3X FLAG tag. Therefore the purification scheme would be similar as purification I 
scheme except performing on-bead 3C cleavage of the CTD followed by releasing 
RNAPII complex from IgG beads with TEV protease.    
The protein detection level by mass spectrometry in CTD-associated and CTD-
less RNAPII from second purification scheme was significantly lower than expected as 
described earlier. In the second purification scheme TEV cleavage was performed 
overnight while RNAPII and associated protein are immobilized on calmodulin beads. 
The interaction of calmodulin with CBP may not be as strong as the interaction of IgG-
coated beads with prot A and could be disrupted under mild condition causing a loss of 
RNAPII subunits along with the associated proteins. Therefore, we concluded that the 
first purification scheme is more efficient than the second scheme and it will be further 
tested to overcome its limitations and to validate its performance in detection protein 
level in wild type and mutant S. cerevisiae. 
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CONCLUSIONS 
The CTD of the largest subunit of RNAPII serves as a platform for the 
recruitment of various transcription factors and accessory proteins. The recruitment of 
these factors and proteins is controlled by the phosphorylation state of the CTD that 
marks each stage of transcription and mediates the coupling of RNAPII transcription with 
RNA processing as well as controlling chromatin modification. 
Mosley and colleagues use TAP purification and MudPIT method followed by 
quantitative proteomics to analyze RNAPII protein interaction network to gain better 
understanding on the regulation of transcription elongation dynamics. Through this 
approach they were able to identify novel regulatory pathways for example identifying 
Rtr1 as a CTD phosphatase that regulates the transition of high Ser5-P level to high Ser2-
P (Mosley et al., 2009).  
Although this approach has proved to be an efficient tool in analyzing RNAPII 
protein interaction network, some limitations have been associated with it including the 
identification of low abundance proteins. Consequently, the focus in the work presented 
here was to improve the quantitative proteomics method used by Mosley laboratory in 
analyzing RNA protein interaction through developing a novel purification method to 
isolate the CTD of RNAPII.   
Wild type yeast strain expressing Rpb1-TEV-CTD and tagged with Rpb3-3C-
TAP was generated in this work as discussed earlier. Subsequently, the CTD-associated 
and CTD-less RNAPII were specifically isolated through the novel purification method, 
which has been demonstrated in western-blot analyses (Figure 12). In addition several 
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proteins involved in transcription have been detected in CTD-associated and CTD-less 
RNAPII by MudPIT analyses including high and low abundance proteins (Table 7 and 8).  
Our data has shown that the novel purification method is an efficient tool for 
quantitative proteomics analysis. Yet, more experiments need to be conducted to validate 
the method and to measure proteins enrichment level in wild type and mutant S. 
cerevisiae using Scaffold quantitative analysis. 
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